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INVESTIGATIONS INTO THE MECHANISMS OF TELOMERE STRUCTURE AND 
FUNCTION 
 
Telomere dysfunction is most commonly defined as critical shortening; i.e., loss 
of telomere sequence due to a variety of causes, usually the end-replication problem.  
However telomeres and their arsenal of associated proteins also provide essential end-
capping structure that protects the ends of linear eukaryotic chromosomes.  The overall 
goal of the studies presented here was to provide new insight into underlying mechanisms 
of telomeric structure and function.   
 We examined the role of telomere function in Acute Myeloid Leukemia.  We 
observed genomic instability in association with radiation-induced AML, and this 
association was observed following AML induction with both gamma (ɣ)- ray and 1 Gev 
56
Fe ion exposure. Furthermore, we observed a clonal fusion event involving telomeres in 
a human AML cell line. Taken together, our AML studies underline the importance of 
genome stability and its link to carcinogenesis.  
We previously reported a role for the DNA damage repair protein DNA-PKcs in 
mammalian telomere end-capping function, where inappropriate telomere fusions, as well 
as telomere fusions to other broken DNA ends, were observed in DNA-PKcs deficient 
backgrounds. DNA-PKcs has many proposed phosphorylation substrates, one of the most 
intriguing and relevant being the recently identified heterogeneous nuclear 




telomeres.  It is also now well accepted that telomeres are transcribed into telomeric 
repeat-containing RNAs, or TERRA, which are thought to contribute to telomeric 
chromatin structure.  Taken together, we hypothesized that DNA-PKcs mediated 
phosphorylation of hnRNA1 plays an important role in tethering TERRA to telomere 
ends, thereby possibly contributing to telomere chromatin structure and function.   
Our data suggests that TERRA localization at telomeres is independent of hnRNP 
A1 and DNA-PKcs kinase activity. Rather, we observed decreased TERRA levels 
following DNA-PKcs kinase inhibition, suggesting DNA-PKcs indirectly regulates 
TERRA levels. Depletion of hnRNP A1 did not influence TERRA levels, but resulted in 
elevated frequencies of what have previously been termed “fragile” telomeres and 
telomere sister chromatid exchange (T-SCE), both indicative of a role for hnRNPA1 in 
facilitating telomere replication. 
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Background and significance 
  One in two American men and one in three American women will be diagnosed 
with cancer in their lifetime according to the American Cancer Society 
(www.cancer.org). Many factors contribute to cancer risk, including smoking, obesity, 
alcohol use and age (National Cancer Institute, 2006). At the cellular level, loss of the 
regulation and function governing cell growth and cell death contributes to tumor growth 
(Hanahan and Weinberg, 2011). Intimately linked to this life and death balance, is the 
regulation of chromosome ends, specialized terminal features termed telomeres. In fact, 
telomere biology has become an integral part of cancer research, the importance of which 
was recently highlighted by the awarding of the 2009 Nobel Prize in Physiology or 
Medicine to Drs. Carol Greider, Elizabeth Blackburn and Jack Szostak for the discovery 
of telomerase, the reverse transcriptase that extends telomere length de novo. 
Functional telomeres provide end-protection by capping chromosomal termini and 
preventing inappropriate fusion events, a vital aspect of maintaining genome stability. 
Our laboratory has been actively investigating telomeric end-capping role(s) of the Non- 
Homologous End Joining (NHEJ) DNA repair protein DNA Dependent Protein Kinase 
catalytic subunit (DNA-PKcs).  We were intrigued by recent studies demonstrating that 
heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1), which associates with 
telomeres, is a phosphorylation substrate of DNA-PKcs (Ting et al., 2009).  Additionally, 
it is now appreciated that telomeres are transcribed into telomere repeat-containing RNA 
or telomeric RNA, termed TERRA or TelRNA, of very heterogeneous lengths, which are 
thought to contribute to telomeric chromatin structure (Azzalin et al., 2007; Deng et al., 




and cancer, where decreased TERRA expression was observed in high grade tumors 
(Schoeftner and Blasco, 2008). We hypothesized that hnRNP A1 may act as an “anchor”, 
tethering TERRA to telomere ends, helping to maintain telomere function and structure.  
Further, we proposed that DNA-PKcs mediated phosphorylation of hnRNP A1 plays a 
critical role in these processes. 
The overall goal of the studies presented here was to provide new insight into the 
underlying mechanisms of telomere structure and function.  We first examined telomere 
dysfunction and genomic instability associated with ionizing radiation (IR) induced 
Acute Myeloid Leukemia (AML) in the CBA mouse model following gamma (ɣ)-ray or 
high-energy ions that have a high charge (Z) and energy (E) (HZE), such as astronauts 
experience to in space (galactic cosmic rays; GCR). 
 Next, we tested our model of functional interaction between hnRNP A1 and 
TERRA at telomeres; i.e., DNA-PKcs mediated phosphorylation of hnRNP A1 regulates 
the presence of TERRA at telomere ends, thus contributing to telomere chromatin 
structure/stability.  We also investigated whether such an association is altered in human 
breast cancer by examining human mammary epithelial cell lines, a possibility suggested 
by decreased DNA-PKcs levels and telomere end-capping failure in the BALB/c mouse 
model (Williams et al., 2009; Yu et al., 2001).  










Telomeres are dynamic nucleoprotein structures consisting of conserved tandem 
repeats of TTAGGG in vertebrates (Meyne et al., 1989). The terminal repeats are directly 
bound by telomere specific proteins including Telomere Repeat Factor 1 (TRF1), 
Telomere Repeat Factor 2 (TRF2) and Protection Of Telomeres 1 (POT 1) (de Lange, 
2005). Together with a plethora of associated telomeric proteins, a higher order 
chromatin structure is formed (Palm and de Lange, 2008). Telomeres end in a 3‟-single-
stranded overhang that folds back upon itself and invades the duplex telomere DNA 
strand, forming a lariat or loop structure (Griffith et al., 1999).  It is believed that this 
telomere (T-) loop structure helps prevent the telomere from being recognized as a 
double strand break (DSB) end in need of repair (Figure 1.1).  
Due to the semi-conservative nature of DNA replication and the inability of 
conventional DNA polymerase to synthesize to the very end, telomeres shorten roughly 
40-200 base pairs per cell division (Counter et al., 1992; Prowse and Greider, 1995; 
Vaziri et al., 1993), a phenomenon known as the end-replication problem (Olovnikov, 
1973; Watson, 1972). Telomere shortening as a function of increasing age has been 
observed in many different tissues (Cherif et al., 2003; Harley et al., 1990). With 
increasing cell division and subsequent telomeric shortening, telomeres eventually reach 
a critically short length, which serves as a signal to stop dividing and initiate senescence 
(Bodnar et al., 1998; Harley and Villeponteau, 1995; Lundblad and Szostak, 1989). 
Cellular senescence involves the activation of p53 and p16
INK4a
, and cells permanently 



















Figure 1.1. A schematic of the T-loop. TRF1, TRF2 and POT1 (not shown) 
bind directly to the telomere sequence. Many other proteins interact with the 
telomere end through protein-protein interactions. The 3‟single-stranded 
overhang invades the duplex DNA, forming a t-loop and a displacement (D)- 
loop. This t-loop structure is believed to cap the chromosome end and protect 




 and experience an irreversible growth arrest (Collado et al., 2007). Senescence serves as 
a tumor suppressor in that it prevents unstable, damaged or mutated cells from continuing 
to divide. Another consequence of critically short telomeres is chromosomal 
rearrangements such as dicentrics, which are lethal to the cell.  
Without senescence or cell death, there would be an accumulation of potentially 
damaged cells. The human disease Dyskeratosis Congenita (DKC) has been linked to 
mutations in telomerase, telomere dysfunction (Vulliamy et al., 2001a), defined as short 
telomeres, and to reduced telomerase activity (Marrone et al., 2004; Vulliamy et al., 
2001b). Short telomeres have also been linked to other age-related diseases, such as 
Werner‟s syndrome (Crabbe et al., 2007; Tahara et al., 1997). Werner‟s Syndrome is 
characterized by pre-mature aging (Gibbs, 1967; Perloff and Phelps, 1958), again 
implicating telomere function in aging. 
In 1985, Carol Greider and Elizabeth Blackburn identified the enzyme that 
circumvents the telomeric shortening dilemma (Greider and Blackburn, 1985). 
Telomerase is a reverse transcriptase that adds species-specific telomeric sequences onto 
the ends of chromosomes de novo. Telomerase consists of an RNA component (TERC) 
and a telomerase reverse transcriptase (TERT) (Greider and Blackburn, 1989; Lingner et 
al., 1997). TERC serves as a template for the addition of telomeric repeats, while TERT 
provides the catalytic activity. Although expressed at very low levels in human somatic 
cells, telomerase is active in stem cell compartments and germ line cells (Chiu et al., 
1996; Hiyama et al., 1996b; Mantell and Greider, 1994; Wright et al., 1996). In order for 
telomerase negative cells to avoid telomere shortening and bypass senescence, telomere 




in human cancers; 85%-90% of human cancers experience telomerase reactivation (de 
Lange, 1994; Kim et al., 1994), while the remainder maintain telomere length by an 
alternative mechanism, termed ALT (Bryan et al., 1998; Cech, 2004). Although the 
mechanism is not well understood, ALT is believed to represent a recombination based 
mechanism of maintaining telomere length in the absence of telomerase, which is most 
often found in mesenchymal tumors (Dunham et al., 2000; Stewart, 2005).   
 
Telomere replication 
 Telomeres are inherently difficult to replicate due to the highly repetitive 
sequence and propensity to form secondary structures, including G-quadruplex structures. 
Replication fork stalling has been observed in telomeres and worsens with the depletion 
of the necessary helicases (Ivessa et al., 2002; Ivessa et al., 2000; Makovets et al., 2004). 
Recently telomeres were proposed as possible fragile sites, where the conditional deletion 
of TRF1 led to what is termed “fragile” telomeres (Sfeir et al., 2009). This was defined as 
an extended telomere or duplicate telomere signal on a single chromatid in metaphase 
cells using Fluorescence In Situ Hybridization (FISH). This phenotype was seen with the 
treatment of aphidicolin, a DNA polymerase inhibitor, and an increase in replication fork 
stalling in the telomeres following the deletion of TRF1 was also observed, both 
implicating that “fragile” telomeres serves an indication of aberrant telomere replication.  
 
Telomeres and radiation 
Since functional telomeres are closely correlated with genomic stability, studies 




noted that short telomeres were predictive of an increase in chromosomal instability 
following treatment in patients with Hodgkin‟s lymphoma (M'Kacher et al., 2007). In 
another study, short telomeres were found to cause increased chromosomal instability and 
apoptosis in mice following irradiation (Goytisolo et al., 2000). Although decreased 
telomere length may seem contradictory to the activation of telomerase in cancer, many 
studies have shown critically short telomeres in cancer. This suggests that even with 
active telomerase, telomeres in cancer are still shortened (Gisselsson et al., 2001). One 
study suggests that telomerase may play a role in repair of radiation-induced double 
strand breaks (DSBs) (Leteurtre et al., 1997).  Interestingly in this study, telomerase 
activity was shown to increase in a dose-dependent manner following gamma-irradiation 
of hematopoietic cells, a finding with important implications for carcinogenesis. 
Together, these studies suggest that telomere length and telomerase activity are linked to 
radiosensitivity. 
 
The role of DNA-PKcs at telomeres 
The DNA-dependent protein kinase (DNA-PK) plays a major role in Non-
Homologous End-Joining (NHEJ), as DNA-PK deficiency results in hypersensitivity to 
ionizing radiation (IR) due to reduced DNA DSB repair (Allalunis-Turner et al., 1995; 
Okayasu et al., 1998). Interestingly, the catalytic subunit of DNA-PK (DNA-PKcs) is 
also vital in telomere end-capping function, as its loss results in the uncapping of 
telomeres (Bailey et al., 2004a; Bailey et al., 1999). An increase in telomere-telomere 
fusions was seen following IC86621 treatment, a specific and potent inhibitor of DNA-




53 (Trp53) knock-out background (Bailey et al., 2004a).  Telomere-DSB fusion events 
were observed following IR exposure, in which uncapped telomeres fused to DSBs, 
which can be distinguished using Chromosome Orientation Fluorescence In Situ 
hybridization (CO-FISH) (Bailey et al., 2004b). Following CO-FISH,  increased telomere 
fusion events were observed specifically involving telomeres produced via  leading 
strand replication (Figure 1.2) (Bailey et al., 2004a). Telomere FISH signals were present 
at the sites of chromosomal fusion, and therefore critically short telomeres were not the 
main contributing factor to these aberrations. Increased telomere fusion events were also 
observed in the BALB/c mouse, which have reduced DNA-PKcs protein levels (Williams 
et al., 2009; Yu et al., 2001). We have shown that the ability of DNA- PKcs to cap 
telomere ends is dependent on the threonine- (Thr) 2609 autophosphorylation cluster 
(Williams et al., 2009). Together, such studies demonstrate that the NHEJ repair protein 
DNA-PKcs plays a vital role in mammalian telomeric end- capping function. The 
preferential role of DNA- PKcs in post replicative processing of leading strand telomeres 
also suggests that regulation of telomere structure may differ between leading and 
lagging strand telomeres. Although evidence supports the kinase activity of DNA-PKcs 
as being necessary for telomere end-capping functions, the underlying mechanisms and 
other possible players involved are unknown. Clearly, more research is needed to 
elucidate the complex regulation of length maintenance and end-capping structure that 


















Figure 1.2. Image of CO-FISH with 
G-rich PNA probe specific for 
telomere sequence labeled with Cy-
3 following inhibition of DNA-PKcs 
kinase activity in p53-/- mouse 
fibroblasts. Arrows depict sites of 
telomere fusion between two 
chromosomes. CO-FISH enables 
differentiation between leading- and 
lagging- strand telomeres. Here the 
probe for the leading strand was 
used, providing evidence that 
inhibition of DNA-PKcs kinase 
activity leads to failure of end-
capping specifically in telomeres 
produced via leading strand 




Heterogeneous Nuclear Ribonucleoprotein A1 and telomeres 
 Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) is an abundant protein 
that belongs to a large family of proteins known to associate with RNA (He and Smith, 
2009). This protein primarily localizes in the nucleus and is involved in mRNA splicing 
and shuttling mature RNA out of the nucleus and into the cytoplasm. Although knock-
down of hnRNP A1 may induce cell death in highly proliferating cells such as cancer 
cells (Patry et al., 2003; Patry et al., 2004), loss of this protein is not lethal, suggesting 
other members of the hnRNP family share in this function (Ben-David et al., 1992). 
Interestingly, hnRNP A1 has been implicated in telomere biology, where it has been 
shown to physically interact with telomere ends (Zhang et al., 2006),  although its role 
has only begun to be explored. Several groups have shown that hnRNP A1 stimulates 
telomerase activity and increases telomere length (Ford et al., 2002; LaBranche et al., 
1998; Zhang et al., 2006). One group demonstrated that hnRNP A1 stimulation of 
telomerase activity was concentration dependent, suggesting that it may actually repress 
telomerase activity when hnRNP A1 is present at greater concentrations (Nagata et al., 
2008).  Interestingly, hnRNP A1 has also been shown to be phosphorylated by DNA-
PKcs in vitro and in vivo (Ting et al., 2009; Zhang et al., 2004).  However, the function 
of this phosphorylation event is unknown. The overall goal of the current studies is to 
investigate a possible role of DNA-PKcs dependent phosphorylation of hnRNP A1 in 
telomere function in two human mammary epithelial cell lines, MCF7 (tumorigenic) and 
MCF 10a (non-tumorigenic). Specifically, we analyzed the effects of DNA-PKcs 
mediated phosphorylation of hnRNP A1 on the possible interaction of hnRNP A1 and 




dependent phosphorylation of hnRNP A1 in MCF7 cells, and our data also provide 
support to the finding that this event is hTR dependent (Ting et al., 2009).  
 
Telomere repeat-containing RNA or Telomeric RNA (TERRA/TelRNA) 
 Telomeric DNA has been considered a „buffer zone,” protecting internal coding 
regions of the chromosome from loss of sequence due to the end-replication problem 
(Olovnikov, 1973; Watson, 1972). Our work has demonstrated that telomeres promote 
genome stability by preventing chromosome ends from being recognized as DSBs 
(Bailey et al., 2004a; Bailey et al., 1999). As tracts of repetitive sequences, telomeres 
have long been presumed transcriptionally silent. Remarkably, recent research provides 
evidence that telomere ends are actually transcribed into telomeric repeat-containing 
RNA (TERRA), also termed telomeric RNA (TelRNA) (Azzalin et al., 2007; Schoeftner 
and Blasco, 2008). To date, TERRA has been identified in humans, yeast, mouse and 
zebrafish, suggesting it is well conserved (Azzalin et al., 2007; Luke et al., 2008; 
Schoeftner and Blasco, 2008). TERRA was found to be very heterogeneous in length, 
ranging from 100 base pairs (bps) to 9 Kbs and predominantly existing as UUAGGG 
repeats (Azzalin et al., 2007; Schoeftner and Blasco, 2008). In these same studies, 
TERRA was shown to localize to telomere ends, suggesting a role in telomere function. 
Decreased TERRA levels have also been associated with cancer progression in human 
tumor samples derived from the colon, larynx and lymph node (Schoeftner and Blasco, 
2008). TERRA is not found at all chromosome ends, suggesting that not all telomere ends 
are transcribed or not all are transcribed at the same time (Azzalin et al., 2007; Schoeftner 




known. Furthermore, the question of whether TERRA acts only at the telomere end from 
which it was transcribed (cis) or at other telomere ends (trans) is largely unexplored. 
Studies have  shown that TERRA may be partly transcribed by RNA polymerase II and 
degraded by the rap1p 5‟-3‟ exonuclease (Luke et al., 2008). Methylation status in the 
subtelomeric region has also been shown to influence the transcription of TERRA (Deng 
et al., 2010; Nergadze et al., 2009; Ng et al., 2009). Telomeric RNA research is in its 
infancy, so little is known regarding the function(s) of TERRA. One proposed role for 
TERRA is involvement in the formation of G-quadruplex structures (Xu et al., 2010; Xu 
et al., 2009). These RNA/DNA hybrid structures may act as regulatory elements at 
telomere ends by preventing access to nucleases and avoiding degradation or by 
preventing access to telomerase and facilitating telomere length maintenance. Recent 
evidence suggests that TERRA may participate in chromatin structure regulation at 
telomeres, as TERRA was shown to associate with proteins known to  be vital in the 
formation of heterochromatin including heterochromatin protein 1 (HP1) and methylated  
(trimethyl) histone H3 (H3K4me3; Figure 1.3) (Deng et al., 2009).  
Because hnRNPA1 has been shown to: 1) bind to UAGGGA/U sequences with 
high affinity (Burd and Dreyfuss, 1994), 2)  associate with telomere ends (Zhang et al., 
2006), and 3) bind DNA and RNA sequences (He and Smith, 2009), we hypothesized 
that hnRNP A1 may play a role in retaining TERRA at telomere ends. Recently, an 
interaction between hnRNP A1 and TERRA has been demonstrated  in vivo via a biotin 
pull-down assay (de Silanes et al., 2010). Here, we investigated whether hnRNP A1 



















Figure 1.3. Schematic depicting the possible role of 
TERRA/TelRNA in promoting heterochromatin formation at 
telomere ends. It has been proposed that TERRA/TelRNA acts to 
stabilize TRF2 interaction with proteins known to promote 
heterochromatin formation including origin of recognition complex 




 hnRNP A1 by DNA-PKcs influenced hnRNP A1 interaction with TERRA. To 
investigate this possibility, we evaluated TERRA localization at telomere ends visualized 
as its colocalization with TRF2, a telomere-specific protein, using RNA FISH and 
immunocytochemistry. We found that TERRA localization at telomere ends was 
independent of hnRNP A1 and DNA-PKcs kinase activity. However, we observed a 
decrease in overall TERRA levels with DNA-PKcs kinase activity inhibition in the 





 Cells encounter daily insult from DNA damaging agents, both endogenous and 
exogenous, including ionizing radiation (IR) exposure. Cells possess an arsenal of DNA 
repair machinery to combat such damage. Cell cycle checkpoints at the G1/S and G2/M 
cell cycle transitions play essential roles in delaying cell cycle progression, in order to 
prevent the propagation of damaged cells and provide opportunity for repair (Elledge, 
1996). There are many DNA damage repair pathways the cell can engage depending on 
the type of damage encountered,  including base excision repair (BER), nucleotide 
excision repair (NER) and double strand break (DSB) repair. DSB repair represents the 
most critical pathway following IR exposure and can proceed by either Homologous 
Recombination (HR) or Non-Homologous End Joining (NHEJ) (Hall, 2006). HR uses 




NHEJ ligates the ends of broken DNA strands with no regard to homology, explaining its 
mutagenic potential and importance for IR-induced DSB repair (Lieber, 2010).  
 
“Sensing DNA damage” 
DNA damage is sensed by Ataxia Telangiectasia Mutated (ATM) and Ataxia 
Telangiectasia and Rad3 related (ATR), which are rapidly recruited to DSB sites 
(Andegeko et al., 2001; Bakkenist and Kastan, 2003).  In addition to DNA-PKcs, ATM 
and ATR belong to the phosphoinositide 3-kinase like (PIKK) superfamily of proteins, 
and ATM is required for the phosphorylation of many proteins involved in DNA repair 
including p53, MDM2, Chk2, histone H2AX and itself (Burma et al., 2001; Canman et 
al., 1998; Khosravi et al., 1999; Matsuoka et al., 1998).   
 
Homologous Recombination (HR) Repair  
The Mre11, Rad 50 and Nbs1 (MRN) complex is also involved in detection of 
DNA damage, as it is recruited to the site of the break and plays a role in end resection 
and the initial recruitment of ATM (Lee and Paull, 2005; Tauchi et al., 2002; Trujillo et 
al., 1998). Breast cancer 1 (BRCA1) and BRCA 2 are then recruited to the site, and 
evidence suggests BRCA1 may regulate the MRN complex exonuclease activity (Paull et 
al., 2001). BRCA2 has been shown to regulate the activity and the availability of RAD51 
(Shivji et al., 2009; Wong et al., 1997; Yang et al., 2005). Rad 51 is loaded onto the 
single stranded overhang and is believed to be involved in strand invasion and exchange 
(Sung, 1994). With strand invasion and branch migration, a Holliday Junction is formed. 




Mus81, RecQ helicase and GEN1 resolvase (Chen et al., 2001; Ip et al., 2008; Wu and 
Hickson, 2003). DNA polymerases fill the gaps and ligase joins the free ends together. 
This process involves minimal loss of sequence at DNA ends and so is deemed a precise 
means of DNA repair. 
 
Non-Homologous End Joining (NHEJ)  
NHEJ is the predominant mode of DNA DSB repair following exposure of 
mammalian cells to IR, as it does not require a homologous template strand, and it occurs 
throughout the cell cycle (Figure 1.4) (Mao et al., 2008; Rothkamm et al., 2003). The 
Ku70 and Ku80 heterodimer (Ku70/80) responds to and binds the broken DNA ends in a 
sequence independent manner (Cary et al., 1997; Falzon et al., 1993; Walker et al., 2001). 
With the recruitment of DNA-PKcs, Ku70/Ku80 translocates inward on the DNA strands 
and away from the DSB site (Dvir et al., 1992; Gottlieb and Jackson, 1993; Yaneva et al., 
1997). Interaction with the DNA-bound Ku70/Ku80 heterodimer  significantly increases 
the kinase activity of DNA-PKcs (Gottlieb and Jackson, 1993). The activated DNA-PK 
holoenzyme possesses serine/threonine kinase activity. DNA-PKcs has many potential 
targets and has been shown to phosphorylate and activate the 5‟-3‟ endonuclease activity 
of Artemis, an important end-processing factor (Ma et al., 2002; Ma et al., 2005). 
However, Artemis does not appear to be essential to NHEJ, as repair still occurs in its 
absence (Wang et al., 2005).  Rather, the MRN complex appears to play the major role in 
DNA end processing (Paull and Gellert, 1999; Trujillo et al., 1998). NHEJ does not 
utilize a homologous template strand, but instead joins DNA ends though sequence 




















Figure 1.4. Non -
Homolgous End Joining 
(NHEJ). The Ku 70/80 
heterodimer is recruited 
to the site of damage. The 
binding of DNA-PKcs to 
Ku70/80 forms the active 
DNA-PK holoenzyme 
complex. The DNA ends 
are processed by the 
MRN complex and DNA 
polymerase fills in the 
gap. Lastly, Ligase IV 
and XRCC4 are required 
for ligation and 
completion of DNA DSB 





the area surrounding the breakpoint (Lieber, 1999; Marvo et al., 1983; Roth and Wilson, 
1986). Following end processing, DNA polymerase fills in the gaps.  
Autophosphorylation of DNA-PKcs is required for its release from the Ku 
heterodimer and DNA ends (Chan and Lees-Miller, 1996), thus freeing the DNA ends. 
Lastly, the ends are ligated by Ligase IV and its associative factor XRCC4 (Grawunder et 
al., 1997; Li et al., 1995).  
 
DNA-repair and Ionizing Radiation (IR) 
Increased radiation sensitivity has been associated with impairments in DNA 
repair factors. For example, severe radiosensitivity was observed in patients deficient in  
ATM, a disorder termed Ataxia Telangiectasia (Gotoff et al., 1967; Morgan et al., 1968). 
Exposing patients to “standard” doses of radiation therapy resulted in tissue necrosis, 
radiation dermatitis and even death. At the cellular level, radiosensitivity can also be 
associated with the loss of regulation of multiple ATM targets, including p53, CHK2, 
BRCA1 and NBS1, critical proteins involved in cell-cycle progression and apoptosis 
(Shiloh, 2001).  Artemis defiency has also been found in a Severe Combined Immune 
Deficiency (SCID) patient, a disease associated with defective V(D)J recombination and 
reduced functional B and T cells (Moshous et al., 2001).  Ku80 deficient mice have also 
been shown to possess a SCID-like phenotype (Nussenzweig et al., 1996), displaying 
increased mortality, loss of hair pigmentation and damage to the gastrointestinal tract 
following ɣ-irradiation; Ku80 deficient embryonic stem (ES) cells showed increased 




Most relevant to our current studies is the evidence suggesting that the loss of 
DNA-PKcs greatly increases radiosensitivity. A human malignant glioma cell line, 
MO59J,  was found to be deficient in DNA-PKcs due to a frameshift mutation that 
produces a truncated protein (Anderson et al., 2001).  Decreased clonogenic cell survival 
and repair of radiation induced damage following ɣ-irradiation was reported   in MO59J 
cells (Allalunis-Turner et al., 1993; Allalunis-Turner et al., 1995).  Decreased ability to 
recover from DNA replication inhibition following x-ray irradiation was also observed in 
MO59J cells,  suggesting that DNA-PKcs also plays a role in replication (Guan et al., 
2000). Additional evidence supporting the essential role of DNA-PKcs in repair was 
provided following treatment of normal human fibroblasts with Wortmannin, a 
phosphatidylinositol 3-kinase (PI-3-K) inhibitor, as decreased repair of DSBs was 
observed by pulse-field gel electrophoresis (Okayasu et al., 1998).  
The SCID mouse possesses a DNA-PKcs gene with an amino acid base 
transversion resulting in a premature stop codon and a severely decreased amount and 
activity of protein (Araki et al., 1997; Blunt et al., 1996; Danska et al., 1996). Following 
x-ray irradiation, SCID cells exhibited slowed DNA repair kinetics and lacked the ability 
to repair sublethal damage (Nevaldine et al., 1997). Polymorphisms in the coding region 
of the DNA-PKcs gene, Prkdc, have also been reported in the BALB/c mouse strain, 
resulting in decreased protein levels and reduced activity (Yu et al., 2001). This 
decreased DNA-PKcs protein expression was associated with increased radiosensitivity 
due to loss of DSB repair efficiency following irradiation (Okayasu et al., 2000; Yu et al., 
2001). Gastrointestinal cells were also observed to be sensitive to radiation in this mouse 




mammary tumors following irradiation has been observed in the BALB/c mouse strain 
(Ullrich, 1983). Together, such studies strongly support the critical role of DNA-PKcs in 
radiation-induced DSB repair, the lack of which contributes to repair deficiency, 
instability and ultimately carcinogenesis.  
 
DNA Protein Kinase (DNA-PK) 
DNA-PKcs is a very large protein, ~460kDa, important for efficient NHEJ and 
V(D)J recombination (Rathmell and Chu, 1994a, b; Smider et al., 1994; Taccioli et al., 
1994). The serine/threonine kinase activity of the DNA-PK holoenzyme has been shown 
to require the presence of linear DNA ends and the Ku 70/80 heterodimer (Carter et al., 
1990; Gottlieb and Jackson, 1993; Lees-Miller et al., 1990). DNA-PK targets a variety of 
proteins for phosphorylation, including Ku70/Ku80 (Lees-Miller et al., 1990), heat shock 
protein 90kDs (hsp90) (Carter et al., 1988; Lees-Miller and Anderson, 1989), c-Jun 
(Bannister et al., 1993), Replication Protein A (RPA) (Boubnov and Weaver, 1995; Brush 
et al., 1994; Pan et al., 1994), p53 (Lees-Miller et al., 1990; Lees-Miller et al., 1992), and 
RNA polymerase II (Peterson et al., 1992). Perhaps the most interesting target of DNA-
PKcs mediated phosphorylation is itself.  The autophosphorylation of DNA-PKcs is 
necessary for the release of the holoenzyme from DNA ends (Chen et al., 2007; Meek et 
al., 2007), allowing access to the ends for completion of repair. DNA-PKcs contains two 
autophosphorylation clusters; six autophosphorylation sites are located in the ABCDE 
cluster (2609-2647) and another six in the PQR cluster (2023-2056) (Chan et al., 2002; 
Cui et al., 2005; Ding et al., 2003; Douglas et al., 2002). A protein with five of the six 




to salvage NHEJ in DNA-PKcs deficient cells (Ding et al., 2003).  One of these 
phosphorylation sites, Thr-2609, was shown to be targeted in DNA repair, where 
phosphorylation occurs following irradiation and DNA-PKcs colocalized with damage 
foci (Chan et al., 2002). Taken together, such evidence suggests that the ability of DNA-
PKcs to undergo phophosphorylation is critical to DNA-repair. Interestingly, the role of 
DNA-PKcs in maintaining telomere end-capping function also requires 
autophosphorylation at the Thr-2609 site (Williams et al., 2009), thus linking DNA-repair 
and telomere function in preserving genomic stability and preventing tumorigenesis.  
 
Ionizing Radiation (IR) 
Introduction 
 Radiation is a unique carcinogen in that it produces large numbers of random 
DSBs. IR exposure presents an interesting contradiction, because it is known to cause 
cancer, as well as cure cancer. Ionizing radiation, as opposed to excitation radiation (non-
ionizing), transfers enough energy to an atom to eject an electron from its orbital. For 
each ionizing event roughly 33eV is released (Hall, 2006), enough to break chemical 
bonds and cause DNA double strand breaks (DSBs), giving it great potential to cause 
damage within the cell.   
 Linear energy transfer (LET) is the rate of energy transferred per unit length along 
the radiation track and is expressed in keV/µm. LET is largely dependent on the mass, 
charge and acceleration of the particle (Hall, 2006). γ-rays produced from a 
137
Cs source 
are a low LET radiation, meaning it is sparsely ionizing. 1 GeV 
56
Fe particles are 




evaluate chromosome and telomere aberration frequencies following exposures to 
different radiation qualities, of relevance to astronaut exposures, in radiation-induced 
AML mice.  
 Because LET is an average measure and may not reflect the variation of energy 
deposition along the track, this qualifying term may be misleading. Another measure of 
radiation quality is relative biologic effectiveness (RBE). RBE is meant to account for the 
fact that the same dose of different radiation types does not necessarily lead to the same 
biological outcome. Generally, RBE is a ratio of the dose of a reference radiation to the 
dose of the tested radiation required to produce the same effect. RBE is a complex 
qualifying factor and depends on the radiation quality, radiation dose, the number of dose 
fractions, dose rate and the end point that is being examined. Radiation involving high-
energy ions that have a high charge (Z) and energy (E) (HZE)  is further complicated in 
that an exposure will produce a high energy, heavy ion radiation track, with associated 
delta rays dispersing from the track. In a previous study examining cytogenetic 
aberrations following Fe-ion and x-ray irradiation, an RBE of 1.3 was observed in 
GM10115 cells, a human-hamster hybrid containing a single copy of human chromosome 
4 (Limoli et al., 2000). In contrast, another study showed no increase in cytogenetic 
aberration frequency following x-ray exposure using colony forming unit type A (CFU-
A) assay, suggesting a much larger RBE as when compared to the marked increase in 
aberration frequency following α-particle exposure (Kadhim et al., 1992). Another study 
suggested that high LET radiation induced more complex aberrations, those involving 3 
or more chromosomes, as compared to low LET radiation (Anderson et al., 2000). 




more efficient at inducing chromosome breaks. With the United States exploring 
possibilities of extended space travel, it becomes critical to define the effects following 
HZE radiation exposure, a cancer risk to astronauts (Cucinotta and Durante, 2006).  
 
Ionizing Radiation-induced cancers 
Breast cancer introduction 
Breast cancer is the one of the most common types of cancer in women; one in 
eight women will develop invasive breast cancer during their lifetime (American Cancer 
Society, 2010c). Over the years, the efforts of researchers and doctors have greatly 
increased the survival rate for breast cancer patients. The discovery of BRCA1 and 
BRCA2 mutations and their role in familial disposition to breast cancer has greatly 
facilitated awareness of the genetic factors that influence breast cancer incidence 
(Hodgson et al., 1999; Peto and Mack, 2000). However, these genes are known to be 
associated with only 5-10% of the total cases of breast cancer (John et al., 2007; Malone 
et al., 2006). Therefore, much remains unknown about the mechanisms of breast 
carcinogenesis.  
Many risk factors for breast cancer have been identified. Gender, or more 
specifically being female, and increasing age are the largest risk factors. Men are about 
100 times less likely to develop breast cancer in their lifetime. Family history of breast 
cancer, exposure to IR, use of post-menopausal hormone therapy, obesity, alcohol 
consumption and not having children until later in life are all associated risk factors 





Breast cancer and ionizing radiation 
 An increased risk of breast cancer following radiation exposure has been well 
documented. A linear dose-response relationship was observed for relative risk of 
developing breast cancer following exposure to IR in female Atomic (A)-Bomb survivors 
(Land et al., 2003; Tokunaga et al., 1987).  Radiation exposures experienced from the A-
bombs differed greatly from other types of exposure because it was acute and delivered at 
a high dose-rate. Increased risk of breast cancer has been seen following other radiation 
exposures as well, e.g. in a pooled analysis of data from eight cohorts including exposure 
due to fluoroscopy and therapeutic x-rays (Preston et al., 2002).  An increased breast 
cancer risk was also observed following radiation treatment for a primary cancer, 
including Hodgkin and Non-Hodgkin‟s Lymphoma (Dores, 2006).  Interestingly, all of 
these studies also reported a correlation between increased breast cancer risk and young 
ages of exposure, suggesting that risk is associated with an early breast developmental 
stage in women. 
 
Breast cancer and telomeres 
Telomerase activity has been well associated with carcinogenesis (Kim et al., 
1994), and telomerase activity has been observed in over 95% of advanced breast cancers 
(Hiyama et al., 1996a).  
Telomere length associated with breast cancer is still debated. Shortened telomere 
length has been implicated in breast cancer, in spite of increased telomerase activity 
(Shen et al., 2007). These results imply that telomerase activity acts to maintain critically 




patients when examining peripheral blood cells (Svenson et al., 2008). This report also 
observed increased survival in patients with shorter telomeres, suggesting that long 
telomeres are the better indicator of poor prognosis and advanced disease. Differences in 
study design may account for some of the conflicting results. Svenson et al. examined 
node positive samples while the stage of disease in Shen et al. study is unspecified. 
Variation in telomere lengths between cells and individuals also complicates an accurate 
assessment. It is clear that more research is required before telomere length can reliably 
be used as a prognostic indicator.  
 The loss of telomere sequence may also contribute to breast carcinogenesis, as 
shown by combined loss of telomerase and p53 in mice, which allowed cells to bypass 
senescence when telomeres became critically shortened (Artandi et al., 2000). Telomere 
dysfunction resulting in breakage-fusion-bridge (BFB) and non-reciprocal translocations 
was observed. Furthermore, mice with severe telomere shortening were at greater 
increased risk of developing breast adenocarcinoma.  
 Another goal of our studies was to examine telomere end-capping function in 
human mammary epithelial cells. We utilized two cell lines, MCF7, a tumorigenic 
epithelial cell line derived from a metastatic pleural effusion, and MCF 10A, a non-
tumorigenic spontaneously immortalized mammary epithelial cell line to evaluate the role 
of hnRNP A1 in telomere function. We sought to elucidate potential differences in the 
regulation of telomere function between tumorigenic and non-tumorigenic mammary cell 
line in relation to hnRNPA1. Although we did observe increased levels of hnRNP A1 in 
the MCF7 cell line, we found that loss of hnRNP A1 affected both cell lines in a similar 




replication, as indicated by an increase in the “fragile” telomere phenotype with the 
depletion of hnRNP A1.  
 
Acute Myeloid Leukemia (AML)  
Introduction 
AML is an aggressive disease of the bone marrow and blood, in which white 
blood cells are unable to differentiate, leading to an accumulation of myeloblasts 
(National Cancer Institute, 2011a). AML has been proposed to be a disease that 
originates in hematopoietic stem cells (Bonnet and Dick, 1997; Lapidot et al., 1994). In 




 cells into lethally irradiated SCID mice 
propagated the disease, suggesting that AML results from a clonal expansion of the stem 
cell compartment.   
Several risk factors are associated with the development of AML including 
smoking, exposure to Benzene and exposure to IR (American Cancer Society, 2010a). 
Approximately four in 100,000 men and three in 100,000 women were diagnosed with 
Acute Myeloid Leukemia (AML) from 2003 to 2007. The five year survival rate for this 
disease is 22.6%, considerably lower in comparison to other cancers such as the 99.1% 
five year survival rate of prostate cancer (National Cancer Institute, 2011b). 
 Diagnosis of AML often depends on the presence of specific chromosomal 
translocation events, and therefore cytogenetics is a vital diagnostic tool (Vardiman et al., 
2009). Chromosome rearrangements often found in patients with AML include t(8;21) 
(Rowley, 1973),  del (16) (Arthur and Bloomfield, 1983) , inv(16) or  t(16;16) (Hogge et 




translocations often form oncofusion proteins; for example t(15;17) fuses PML and 
RARA genes (Borrow et al., 1990; de The et al., 1990). In contrast to the common 
chromosome translocations often observed in de novo AML, losses in chromosome 5 and 
7 have been noted in therapy-related AML (t-AML) (Liang et al., 1998; Nagarajan, 
1995).  
   
AML and ionizing radiation 
 An association between AML and irradiation was noted in patients following x-
ray radiotherapy for the inflammatory disease ankylosing spondylitis  (Court-Brown and 
Doll, 1957). Additional evidence linking AML to radiation exposure was provided by 
atomic bomb survivors. In 1947, shortly after the bombs fell over Hiroshima and 
Nagasaki, the U.S. Atomic Bomb Casualty Commision (ABCC) began studying 
hematological disease as a possible effect of radiation on survivors (NAS, 2010). These 
initial studies led to a comprehensive larger population-based study termed the Life Span 
Study (LSS), which continues to this day and investigates the effects of radiation on 
carcinogenesis. Taken together, such studies provide evidence that AML is the most 
frequent type of hematological cancer following exposure to radiation from atomic 
bombs (Preston et al., 1994; Richardson et al., 2009). An association between AML and 
ionizing radiation is strongly supported, and evidence suggests that dose response is a 
linear-quadratic function, where the slope increases with doses up to 3-4 Gy and 





 Although leukemia is a relatively rare cancer, its increased risk following IR 
exposure is disconcerting, especially to those who may be exposed to it routinely in their 
occupation. One striking example is astronauts, who are exposed to galactic cosmic rays 
(GCR) and solar proton events (SPE) during space travel (NASA, 2000). A possible 
mission to Mars, lasting approximately 3 years, could mean a whole body dose of 1 
Sievert (SV) or more (Wilson et al., 1995). During such missions, astronauts may be 
exposed to protons, high-energy heavy (HZE) ions and secondary radiations such as 
neutrons and delta rays (Cucinotta and Durante, 2006).  While there is considerable data 
on cancer risk following exposure to gamma rays from atomic bomb survivors, informed 
cancer risk estimates following exposure to HZE ions are not available in humans.   
  
Sfpi1/PU.1 in AML 
Mouse models of AML are in agreement with the observed increases in human 
AML following radiation exposure. The CBA inbred mouse strain is often used in AML 
studies due to their low spontaneous incidence of AML and high incidence following 
irradiation (Rithidech et al., 1999).  Similar to the dose response seen following radiation 
exposure in A-Bomb survivors, AML incidence in CBA mice exposed to x-irradiation 
peaked between 1.5-3 Gy (Major and Mole, 1978).   
Early cytogenetic analysis revealed deletions in chromosome 2 associated with 
radiation induced AML in the bone marrow of whole body irradiated mice (Bouffler et 
al., 1996; Hayata et al., 1983). Chromosome 2 hypersensitivity following irradiation was 
shown via chromosome painting and was two-fold higher as compared to chromosome 1 




defined and mapped to a minimal deleted region by examining loss of heterozygosity 
through microsatellite analysis and mapping (Alexander et al., 1995; Clark et al., 1996; 
Silver et al., 1999). Within this defined region, possible tumor suppressor genes were 
identified and narrowed to three of interest, Ddb2, Madd and PU.1 (Cook et al., 2004). 
The remaining allele of these three genes was sequenced; of these only point mutations 
targeting Arginine 235 (Arg235) and other codons were observed in the E-twenty-six 
(Ets) domain of PU.1, supporting a causative role in leukemogenesis.  
PU.1 is a transcription factor encoded by the Sfpi1 gene that is critical for 
hematopoiesis and differentiation of bone marrow progenitor cells (Dakic et al., 2005; 
Iwasaki et al., 2005). Reduced levels of PU.1 have been associated with an expansion of 
immature myeloid cells (Houston et al., 2007). A conditional knockout of PU.1 led to the 
development of AML in C57BL/6 mice (Metcalf et al., 2006). These murine studies 
provide substantial supporting evidence for an association of AML with loss of PU.1.  
 Recently, Peng and colleagues quantified the percent PU.1 deletion following 
radiation exposure of different qualities and dose (Peng et al., 2009). Using Fluorescence 
In Situ Hybridization (FISH), bone marrow cells were examined in CBA/Ca and AML-
resistant C57BL/6 mice following 1GeV/nucleon 
56
Fe, ɣ- and x-irradiation in order to 
evaluate effects of radiation quality and PU.1 loss. Increased PU.1 loss was observed in 
ɣ- and 
56
Fe- irradiated cells one day following irradiation in CBA/Ca and C57BL/6 mice. 
At one month, PU.1 loss in C57BL/6 decreased to levels similar to that seen without 
irradiation.  Furthermore, at one month following irradiation, the percent of PU.1 loss 
following 1Gy 
56
Fe decreased in CBA/Ca mice. The dose response for 
56
Fe leveled out at 
0.2 Gy (Figure 1.5 and 1.6). Peng et al. concluded that although 
56




PU.1 loss, its damaging effects caused the loss of these cells from the bone marrow cell 
population. However, this frequency increased one year post irradiation. The relative 
biological effectiveness (RBE) for PU.1 loss was calculated at one day post-irradiation to 
be ~3-3.5 for 
56
Fe. However, for AML induction, the RBE was proposed to be ~1 (Weil 
et al., 2009), illustrating how RBE calculations are confounded by the endpoint and time 
point evaluated. 
 
AML and telomeres/ radiation 
 Although increased telomerase activity in both human and murine AML has been 
reported, the presence of shortened telomeres has also been observed (Hartmann et al., 
2005; Rithidech et al., 2001). Critically shortened telomeres may contribute to the 
formation of chromosomal abnormalities in human AML (Hartmann et al., 2005; 
Swiggers et al., 2006). Conversely, when telomere length was examined in murine AML, 
telomere shortening was neglible, and therefore may not play a major role in murine 
leukemogenesis (Meijne et al., 1996). Finnon et al. provided evidence that although 
telomeres were long in a mouse AML cell line (7926), telomere dysfunction and not 
shortening actually sensitized the 7926 cell line to radiation-induced chromosomal 
aberrations as compared to its AML mouse cell line counterpart (8709), which displayed 
little telomere dysfunction (Finnon et al., 2001).  These findings suggest that although 
telomere length is maintained in murine AML, telomere dysfunction cannot be ruled out 
as a possible mechanism. However, whether telomere dysfunction plays a role in the 

























Figure 1.5. Graphs depict dose response for PU.1 loss measured by FISH using a 
bacterial artificial chromosome (BAC) probe for PU.1. Timepoints examined 
include 1 day, 1 month and 1 year post irradiation for 
56
Fe and 1 day and 1 month 
for 
137
Cs. Graphs show the sustained loss of PU.1 long after irradiation in the 


























 We examined chromosomal aberrations and telomere end-capping function 
associated with PU.1 loss following ɣ- and HZE irradiation of CBA and C57BL/6 mice. 
Our studies evaluated chromosomal instabilities in cells many generations following 
radiation exposure. To further analyze the instability observed in clonal progeny, cells 
were injected into radiation ablated recipient mice and subsequent individual spleen 
colonies were evaluated for chromosomal aberrations. Analysis of spleen colonies 
provided a means to isolate and examine single clones for telomeric and chromosomal 
instabilities early in the process of tumorigenesis. Our purpose was to evaluate the 
generation and role of ongoing instability in the process of leukemogenesis. We also 
examined potential differences based on radiation quality following ɣ- versus HZE 
irradiation in an effort to assess related carcinogenetic effects.  
 
Conclusions 
 Our goal in the present studies was to better elucidate the mechanisms in telomere 
structure and function. First, we examined a possible correlation between telomeres, 
genomic instability and the development of IR-induced murine AML. We found an 
association between increased chromatid-type aberrations, indicative of on-going 
instability, and IR-induced murine AML. We analyzed spleen colonies using the CFU-S 
assay and found increased instability at our 5 day time point in CBA/Ca mice, suggesting 
that this instability may contribute to cancer initiation. We also found evidence of 
telomere end-capping dysfunction in human AML, using a human AML cell line. Taken 
together, these data support genomic instability contributing to murine IR-induced AML.  




may contribute to chromosomal instability in human AML, as demonstrated in our 
human AML cell line.  
We next analyzed the interaction of DNA-PKcs, hnRNP A1 and TERRA at 
telomeres. We found evidence that hnRNP A1 plays a role in the correct and efficient 
replication of telomeres, as evident with the presence of “fragile” telomeres, as 
previously described in TRF1 deficient mice (Sfeir et al., 2009). Although we did observe 
a decrease in hnRNP A1 phosphorylation following decreased DNA-PKcs or kinase 
activity, we did not observe a change in TERRA localization at telomeres following 
siRNA silencing of hnRNP A1. Interestingly, we found decreased TERRA localization 
was independent of hnRNP A1 and DNA-PKcs kinase activity. We also observed a 
decrease in overall TERRA levels following DNA-PKcs kinase inhibition, suggesting the 
kinase activity of DNA-PKcs may indirectly affect TERRA levels.  
Altogether, our studies provide evidence for the vital role of telomere end-capping 
structure and function. In addition to the proposed roles of hnRNP A1 in telomere length 
maintenance and telomerase activity, we also provide evidence for its role in telomere 
replication. We also provide evidence that TERRA localization at telomeres does not 
require hnRNP A1 or DNA-PKcs kinase activity.  Furthermore we present data 
suggesting a novel role for DNA-PKcs, where DNA-PKcs kinase activity affected the 
total levels of TERRA although the mechanism of this interaction remains to be explored. 
The data shown here emphasize the complex regulation of telomere maintenance. Since 
the initial observation of telomeres and the importance of their role in chromosome end 
protection by Herman Muller and Barbara McClintock (McClintock, 1939; Muller, 




the mechanisms that protect the telomeres from being recognized as broken DNA ends. 
However, we still have much to learn about telomeres, as evidenced by the recent 
observation that telomeres are transcribed into TERRA. TERRA has been implicated in 
maintaining chromatin structure, and evidence also suggests that DNA-PKcs is important 
in telomere end-capping. Therefore, one could speculate that the DNA-PKcs regulation 
of TERRA may aid in facilitating end capping function. We provide evidence that 
hnRNP A1 is required for efficient telomere replication and suggest a role for DNA-PKcs 
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Overview 
Space exploration poses many hazards, including exposure to Galactic Space 
Radiation (GSR), which includes, among other species, high energy, high atomic mass, 
heavy ions (HZE) (Cucinotta and Durante, 2006; Wilson et al., 1995).  The cancer risk 
associated with such densely ionizing exposures is largely unknown.  To help better 
assess such risk, we examined chromosomal instability (CIN) in a murine model 
(CBA/Ca mice) of radiation-induced acute myeloid leukemia (AML) following HZE 
particle (1 GeV/n 
56
Fe ions) or 
137
Cs gamma (ɣ)-ray exposures.  We found no significant 
difference in the frequencies of chromosome-type or telomere aberrations in the mice that 
developed AML after exposure as compared to their respective controls.  However, an 
increased frequency of chromatid-type aberrations following both types of exposures was 
observed in leukemic cells from AML mice, providing supporting evidence of on-going 
instability, which was independent of age.  Our results also did not support a direct link 
between chromatid-type aberrations and loss of Pu.1 (Sfpi1), a transcription factor 
previously shown to be correlated with radiation-induced murine AML (Cook et al., 
2004; Peng et al., 2009).  Lastly, we examined two human AML cell lines and found 
elevated frequencies of both chromosome and chromatid-type aberrations.  We also 
identified a clonal telomere aberration associated with a previously identified 
chromosome translocation.  Taken together, our results support chromosomal and 






 Acute Myeloid Leukemia (AML) is characterized by the uncontrolled 
proliferation of immature myeloblasts in the bone marrow (National Cancer Institute, 
2011).  The accumulation of these aberrant cells displaces healthy blood cells, resulting 
in infections and/or anemia. AML is often associated with certain chromosomal 
aberrations, including t(8;21) (Rowley, 1973), del (16) (Arthur and Bloomfield, 1983), 
inv(16) or t(16;16) (Hogge et al., 1984; Le Beau et al., 1983) and t(15;17) (Rowley et al., 
1977).  Chromosome aberrations associated with therapy related AML (t-AML) differ 
somewhat, in that deletions involving chromosome 5 and 7 are most often observed 
(Liang et al., 1998; Nagarajan, 1995; Smith et al., 2003). Although, AML is relatively 
rare, occurring in 3.5 per 100,000 people, it is a devastating disease and its cure rate 
remains low, 22.6% (National Cancer Institute, www.cancer.gov.statfacts).  
Development of some AMLs has been linked to exposure to ionizing radiation 
(IR). For example, AML has been shown to be the most common and earliest arising type 
of cancer in the atomic (A-) bomb survivors (Preston et al., 1994; Richardson et al., 
2009). This unique cohort of individuals experienced an acute, high dose rate exposure, 
and so, may not represent the true induction of AML following other less instantaneous, 
chronic radiation exposures.  While, the dose-response relationships have been 
extensively examined in the A-bomb survivors, these studies also do not aid in the 
understanding of cancer risk following exposures to different radiation qualities, 
including highly ionizing, high energy particles (HZE). 
 HZE radiation exposures to astronauts during space travel represent an unknown 
cancer risk. A mission to Mars, for example, is estimated to take approximately three 




al., 1995).  Although Galactic Space Radiation (GSR) primarily involves exposure to 
protons and low Linear Energy Transfer (LET) particles, high LET HZE are a primary 
concern (Cucinotta and Durante, 2006; Durante and Cucinotta, 2008). Because 
information on human exposure to HZE radiation is not available, animal studies and 
modeling are especially valuable. 
 PU.1 (Sfpi1) encodes a transcription factor involved in differentiation of 
progenitor cells during hematopoeisis, has been strongly correlated with murine AML 
(Cook et al., 2004).  PU.1 regulates the differentiation of multipotent lymphoid and 
myeloid progenitor cells by interacting with other transcription factors, including AML-1 
(Vangala et al., 2003), c-jun (Behre et al., 1999) and GATA-1 (Rekhtman et al., 1999; 
Zhang et al., 2000).  The loss of PU.1 also leads to reduced responsiveness to cytokines 
responsible for the differentiation of progenitor cells into the myeloid lineage, including 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony 
stimulating factor (M-CSF) (Dakic et al., 2005). Peng et al, assessed bone marrow cells 
for the loss of PU.1 located on chromosome 2 in the CBA/Ca mouse model following 
gamma (ɣ-), x- or 1 GeV/n 
56
Fe irradiation (Peng et al., 2009).  PU.1 loss was observed 
one day post irradiation following all three types of radiation, with HZE exposure being 
the most effective in inducing PU.1 loss. By 30 days, however, levels of PU.1 loss 
decreased in HZE samples but remained high in CBA/Ca mice exposed to x- or ɣ-
irradiation. Interestingly, an increase in the loss of PU.1 reemerges one year post HZE-
irradiation in exposed CBA/Ca mice. These studies propose that the assessment of PU.1 





 Genomic instability has previously been reported  following radiation exposure 
(Kadhim et al., 1994; Watson et al., 2001) and in atomic bomb survivors with 
Myelodysplastic Syndrome (MDS) or AML (Nakanishi et al., 1999). Genomic instability 
may facilitate selection of chromosomal changes that allow the cell to bypass cell cycle 
regulation and/or death and thereby contribute to cellular transformation. Mammary 
epithelial cells isolated from the IR-induced breast cancer susceptible BALB/c mouse 
strain showed an increase in delayed cytogenetic instability versus the resistant C57/BL6 
strain 16 population doublings post ɣ-irradiation (Ponnaiya et al., 1997b), supporting a 
link between instability and tumorigenesis. Similar results were observed following 
neutron irradiation in MCF 10a human mammary epithelial cells (Ponnaiya et al., 1997a).  
 One possible factor contributing to genomic instability is telomere dysfunction. 
Telomeres are repetitive features at the ends of chromosomes that protect them from loss 
of genomic sequence due to the end-replication problem (Olovnikov, 1973; Watson, 
1972) and inappropriate chromosome fusion events.  We have demonstrated loss of 
telomere end-capping function in cells deficient in DNA protein kinase catalytic subunit 
(DNA-PKcs), activity, which results in telomere fusion events (Bailey et al., 2001; Bailey 
et al., 1999). Although some chromosome aberrations (e.g. dicentrics) are lethal to the 
cell, others are less deleterious and so are transmissible; some can lead to breakage-
fusion-bridge (BFB) cycles that propagate cytogenetic instability (Rudolph et al., 2001; 
Stewenius et al., 2005).  Previous studies have shown that loss of telomere sequence or 
function also contributes to instability (Finnon et al., 2001; Hartmann et al., 2005; 




 Here, we demonstrate delayed genomic instability in splenocytes of CBA/Ca mice 
with AML following both ɣ- and HZE exposure. The CBA mouse provides an 
informative model system due to its low spontaneous rate of AML and high efficiency of 
AML induction following irradiation (Rithidech et al., 1999). Using the Colony Forming 
Unit-Spleen (CFU-S) assay 5 days post HZE exposure, we observed increased instability 
in some spleen colonies isolated from CBA/Ca mice as compared to those from C57BL/6 
controls. Aberration frequencies decreased by 7.5 months, our latest time point. We did 
not observe significant telomere instability; however, the inherent differences between 
mouse and human telomere biology may have masked dysfunction. Therefore, we also 
assessed two human AML cell lines for chromosomal instability and found increased 
telomere-, chromatid- and chromosome-type aberrations, all indicative of inherent 
instability. Furthermore, we identified a clonal telomere fusion event involved in a 
translocation, suggesting that telomere dysfunction may contribute to overall instability 
observed in human AML.  
 
Materials and methods 
Cell culture 
Two human AML cell lines, KG-1a and UoC-M1, were generous gifts from Dr. 
Michelle Le Beau at the University of Chicago. KG-1a cells were maintained in Iscove‟s 
Modified Dulbecco‟s Media (IMDM) supplemented with 10% FBS, 1 % 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1x Pennicilin/streptomycin, and 




Pennicilin/streptomycin and 1% HEPES. Cells were passaged 1-2 times per week and 
media was changed every 3-4 days.  
 
Mononuclear cell isolation 
 Normal human cord blood was obtained from the University of Colorado Cord 
Blood Bank in Aurora, CO. Mononuclear Cells (MNCs) were isolated using lymphocyte 
separation media (LSM, Mediatech), a density gradient media. In brief, cord blood was 
diluted with Magnetic Sorting Buffer (MACs; 1X PBS, Ca+ and Mg+ free with 0.5% 
BSA/2mM EDTA) and layered with LSM. Cells were centrifuged, the interphase layer 
was collected and washed with repeated centrifugations to isolate MNCs.  
  
Radiation and AML induction 
CBA/Ca mice were exposed at 8-12 weeks of age to 1.0, 2.0 or 3.0 Gy ɣ-rays 
(
137
Cs source, a J.L. Shepherd Model 81-14, located at Colorado State University)  or 0.1, 
0.2, 0.4 or 1.0 Gy doses of 1 GeV/n 
56
Fe (NASA Space Radiation Laboratory (NSRL) at 
the Brookhaven National Laboratory, New York). Mice were monitored for enlarged 
spleens, which were collected, dissociated and briefly cultured; AML was confirmed by 
histopathology on part of the collected spleen.  Mice that remained in the mouse colony 
though out the study, which were age matched but not exposed to radiation served as 
controls. 
A total of 14 CBA/Ca mice with AML following ɣ-irradiation were used for this 
study. Out of these 14 mice, one received 1 Gy, seven 2 Gy and six 3 Gy. Three CBA/Ca 
mice with AML following HZE (1 GeV/n 
56




which were exposed to 1 Gy and one to 0.4 Gy.  The low number of HZE-induced AMLs 
reflects the low efficiency of 1 GeV/n Fe particles at inducing AML as compared to ɣ-
irradiation (Weil et al., 2009). Irradiated mice that did not develop AML were also 
included in the study, including six exposed to ɣ-rays and 19 exposed to 
56
Fe ions. Five 
control age-matched mice, sham irradiated, were included in the study and were 
subjected to the same histopathological analysis as irradiated mice. Four young, 8-12 
weeks of age, CBA/Ca mice were also included in order to examine age effects on 
aberration frequencies.  A total of 663 metaphases were scored in the ɣ-induced AML 
group, 84 in the HZE-induced AML group, 139 in the age-matched non-irradiated group 
and 103 in the young mice. Another 198 metaphases were assessed from mice that did 
not develop AML following ɣ-ray exposure and 490 metaphases following HZE 
exposure. A total of 1677 metaphases were scored in total.  
 
Fluorescence In Situ Hybridization (FISH) 
Slides for cytogenetic analysis of whole spleen and spleen colonies were prepared 
using adapted standard protocols (Becker et al., 1963; Henegariu et al., 2001). Spleens 
were minced and incubated with RPMI 1640 (Gibco) with 20% FBS and 1x Glutamax. 
Concanavalin A (Sigma) was added to the media at a concentration of 5µg/mL, and cells 
were incubated overnight at 37ºC with 5% CO2. Colcemid was added at a final 
concentration of 0.1µg/mL, and cells were incubated for another 3-4 hours. Cells were 
collected, centrifuged and incubated in 0.75M KCl and fixed in 3:1 methanol and acetic 
acid. Cells were dropped directly onto clean, prepared slides. FISH was performed using 




(DAKO).  Following pre-treatment, slides were denatured in 70% formamide, 2XSSC at 
75ºC. The probe was hybridized at 37ºC for 2 hours in the dark, and the slide was washed 
in 70% formamide, 2xSSC for 15-20 minutes at 32ºC in a shaking water bath. Slides 
were mounted with antifade and counterstained with Vectashield and 4‟6-diamidino-2-
phenylindole, dihydrochloride (DAPI; Vector Laboratories).  Images were obtained using 
a Zeiss Fluorescence microscope (Axioplan 2ie MOT) and charge-coupled device (CCD) 
camera (model CV-m4
+
CL, JAI PULNiX incorporated).  ISIS FISH imaging systems 
software (Metasystems) was used for image capture and analysis.  
 
Colony Forming Unit-Spleen (CFU-S) 
 The colony forming unit-spleen assay (CFU-S) has been previously described 
(McCulloch and Till, 1962; Till and Mc, 1961). Donor male CBA/Ca or C57BL/6 mice 
(8-12 weeks) were exposed to 1 Gy of 1 GeV/n 
56
Fe ions, at the NSRL located at 
Brookhaven National Laboratory in New York. Following 5 days or 7.5 months, the mice 




 bone marrow 
cells were injected into lethally irradiated (8.2 – 9.0 Gy of ɣ-irradiation) recipient female 
CBA/Ca or C57BL/6 mice. Twelve days later, the recipient mice were humanely 
sacrificed and spleen colonies collected and processed for cytogenetic analysis. For 
spleen colonies aberration scoring, 11-31 metaphases were assessed per colony, with a 







Aberration scoring criteria 
Only metaphases with a near diploid chromosome number (~40) were scored; 
aneuploidy was not observed in these samples. A chromatid gap was defined as a 
discontinuity in the DAPI stain that was less than the width of a single chromatid arm. 
Chromatid breaks were defined as discontinuities in the Dapi stain that were equal to or 
greater than the width of a chromatid arm. Differences in numbers were accounted for 
when perfoming statistical analyses. Statistical analysis was done using T-tests 




In order to examine telomere function in radiation-induced murine AML, we 
evaluated telomere aberrations, including telomere associations, internal telomeric 
signals, telomere fusions and telomere duplication events. We found no significant 
increase in any individual category of telomere aberration in the AML samples. Telomere 
associations were observed at a higher frequency throughout all samples, but were not 
significant when compared between the AML groups and the controls (data not shown). 
Even when all telomere aberrations were grouped into one category, no significant 





Chromosomal instability in radiation-induced AML was evaluated in leukemic 




chromosome-type aberrations. Chromatid-type aberrations included chromatid gaps and 
breaks, iso-deletions and chromatid type exchanges. A significant increase in chromatid-
type aberrations was observed in AML samples induced by both ɣ- and HZE- irradiation 
(Figure 2.1), consisting primarily of chromatid gaps and breaks. Because chromatid-type 
aberrations arise in the cell-cycle of collection, they are indicative of on-going instability. 
This increase in chromatid-type aberration frequency was also significant when 
comparing leukemic cells from radiation-induced AML mice versus splenocytes from 
irradiated mice that did not develop AML (Figure 2.2). Controls were age-matched with 
the mice that developed AML; the control mice were aged due to the latency of AML 
development, which can be up to two years. Therefore we also examined aberration 
frequencies in young non-irradiated mice to confirm that the increased instability was not 
due to increased age (Figure 2.2).  No increase in either telomeric or chromatid-type 
aberrations in the younger mice was observed, suggesting that age was not a contributing 
factor. A significant increase in chromosome aberrations was seen in the older age group 
when compared to the young age group,  an expected result, as increased chromosome-
type aberrations do occur with increased age (Tucker et al., 1999). 
 
Chromosome-type Aberrations 
We evaluated chromosome-type aberrations, including terminal deletions, 
dicentrics and robertsonian translocations. We saw no significant increase of 
chromosome aberrations in AML samples when compared to the controls (Figure 2.1). 
As with telomere-type and chromatid-type aberrations, we combined all chromosome 















Figure 2.1. Increased chromatid-type aberration frequency in CBA/Ca mice with 
radiation-induced AML. A) Representative mouse metaphase spread hybridized 
with PNA G-rich telomere probe labeled with Cy-3. Arrows depict chromosome 
breaks. B) Arrows depict chromatid break and robertsonian translocation. C) All 
aberrations in each category were grouped together (e.g. total telomere 
aberrations). Average total telomere aberration frequencies per metaphase and 
average total chromosome aberrations were not significantly different between ɣ-
induced AML (blue) and 
56
Fe-induced AML (red) or non-irradiated, splenocytes 
harvested from age-matched control group (green). A significant increase in 
chromatid-type aberrations was seen when comparing ɣ-induced AML with non-
irradiated controls (**, p=0.01) and when comparing 
56
Fe-induced AML with 







































chromosomal-type aberration frequency following either ɣ- or HZE exposure as when 
compared to control samples. 
 
Compared to PU.1 loss 
Radiation-induced AML in CBA mice has been correlated with PU.1 loss (Peng 
et al., 2009). We, therefore, compared aberration frequencies to PU.1 loss, hypothesizing 
that a high PU.1 loss might be associated with samples that exhibited a greater increase in 
chromosome aberration frequency. However, no correlation between aberration 
frequency and PU.1 loss was seen, suggesting the mechanism underlying PU.1 loss was 
independent of the increase in chromatid-type aberrations we observed (Figure 2.2). 
 
Colony Forming Unit-Spleen (CFU-S)  
In order to determine if instability occurs as an early event in leukemogenesis, we 
assessed chromosome aberrations in spleen colonies utilizing the CFU-S assay. We 
analyzed colonies at day 5 and 7.5 months post-irradiation using 1 Gy of 1 GeV/n 
56
Fe. 
We observed instability at the 5 day time point, which was especially apparent when 
compared to spleen colonies examined in C57BL/6 mice (Figure 2.3). C57BL/6 mice 
have been shown to be resistant to radiation-induced AML (Darakhshan et al., 2006). 
Most metaphases possessing aberrations from C57BL/6 colonies exhibited only one 
chromatid aberration.  An increased frequency of chromatid-type aberrations was 
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Figure 2.2. Increased chromatid aberration frequency following IR is specific to mice 





Fe-irradiated non-AML (purple), ɣ-induced AML (blue), ɣ-irradiated 
non-AML (red) and non-irradiated controls (gray) in CBA/Ca mice. A significant 
increase in chromatid-type aberrations was seen when comparing radiation-induced 
AML (p=0.05) versus samples that are irradiated and did not develop AML, as well as 
non-irradiated controls. B) The average frequency of aberrations per metaphase was 
examined in old (purple) versus young (light grey) mice. No increase in chromatid-type 
aberrations was observed, suggesting age is not a major contributing factor for the 
increase in chromatid-type aberrations seen in radiation-induced AML mice. The 
frequency of chromosomal-type aberrations was significantly increased when compared 
to young non-irradiated controls (p=0.05) C) Aberration frequency per metaphase was 
examined for an association with PU.1 loss. There was no significant difference 
between those AML samples that exhibited low PU.1 percent deletion (<7%, light blue) 
and high PU.1 percent deletion (>85%, dark blue). Grey bars are included here as the 
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Figure 2.3. Increased chromatid-type aberrations using CFU-S assay suggests instability may be an early event in AML 
development. An increase in the number of colonies with 1 or more aberrations is seen at the 5 day time point in 
CBA/Ca mice as when compared to C57BL/6. However at the 7.5 months time point, the number of colonies with 
aberrations in CBA/Ca mice is similar to that seen in C57BL/6 mice.  The complexity, as determined by the number of 
























1 2 3 >3 
CBA/Ca 5 day 8/17 19/304 (6.25) 15 3 1 0 24 10 
 7.5 
month 
3/17 4/281 (1.4) 3 1 0 0 5 4 
C57BL/6 5 day 4/17 5/321 (1.6) 5 0 0 0 5 3 
 7.5 
month 





It would be of interest to examine the frequency of aberrations in spleen colonies 
post ɣ-irradiation. However, we were unable to evaluate this group, due to limits of 
mouse colony maintenance.  
 
Instability in human AML cell lines 
Due to the fact that mice express telomerase activity in all their tissues 
(Chadeneau et al., 1995; Prowse and Greider, 1995), aberrations arising from telomere 
length abnormalities associated with murine AML are confounded. We, therefore, 
assessed two human AML cell lines for telomere-, chromatid- and chromosome-type 
aberrations using FISH with a telomere specific G-rich PNA probe labeled with Cy-3. 
Increases in telomere-type, chromatid-type and chromosome-type aberrations were seen 
in both AML cell lines versus mononuclear cells (MNCs). Due to the low number of 
observed aberrations, statistical analysis was not appropriate.  However, we did identify a 
clonal aberration (translocation) involving telomeres in the KG-1a AML cell line (Figure 
2.4).  This clonal event was not included in the analysis for total aberration frequencies. 
Because abundant telomere signal is evident at the point of fusion, this event is likely not 
due to critical telomere shortening. Rather, we conclude that this fusion event is 
indicative of telomere dysfunction resulting from loss of end-capping structure. This 
result suggests that DNA repair deficiency may underlie the observed loss of telomeric 














































Figure 2.4.  Evidence of instability in human AML cell lines. A) An increase in 
telomere-type, chromatid-type and chromosome-type aberrations in KG-1a cells 
(dark blue) and UoC-M1 cells (light) when compared to control MNCs (yellow). 
B) A clonal aberration involving telomere ends was observed in KG-1a cell line, 









Chromatid-type aberrations are obliged to occur in the cell cycle in which they are 
collected, as after replication they present as chromosome-type aberrations. This 
informative end point is indicative of on-going, delayed instability. In contrast to the data 
we present here, an increased frequency of chromatid and chromosome-type aberrations 
has been previously reported in hematopoietic cells following low dose alpha (α)-particle 
exposure but not following X-ray exposure, suggesting that high LET radiation induces 
instability, while low LET does not (Kadhim et al., 1994; Kadhim et al., 1992). In this 
work, a relative biologic effectiveness (RBE) approached infinity when examining 
chromosomal aberrations as an endpoint. In the Kadhim et al. studies, hematopoietic cells 
from CBA/H were irradiated in vitro, plated and assayed using the colony-forming unit 
type A (CFU-A). In contrast to the Kadhim et al. studies, increased instability was 
observed in cells irradiated with low LET irradiation when examined in vivo, suggesting 
the lack of aberrations presented by Kadhim et al. may partly be due to in vitro artifacts 
(Watson et al., 2001). This study used the CFU-S assay with bone marrow of CBA/H 
mice following either α-particle or x-ray exposure to examine the delayed effects of 
radiation; similar to our studies, most aberrations were of the chromatid-type. Watson et 
al. also reported cells displaying chromosomal instability in approximately 3-6% of cells 
following either 3 Gy x-ray or 0.5 Gy of α-particle exposure using the CFU-S assay. In 
our studies, we observed approximately 1-6% of cells displaying chromatid aberrations, 
falling relatively close to the percentage Watson et al. reported. Differences may be 
accounted for when considering the different time points, doses, radiation qualities, as 




the expression of aberrations and aberration type. Instability following low LET 
irradiation has been shown to require a greater delay in some cell types (Kadhim et al., 
1998; Ponnaiya et al., 1997a).  Lastly, Ullrich et al. and Tucker et al. provided further 
support for increased chromosomal instability following radiation exposure in their 
studies, where in vivo exposure to 
137
Cs ɣ-irradiation led to increased instability as 
manifested by chromatid-type aberrations (Turker et al., 2004; Ullrich and Davis, 1999). 
Ullrich et al. also showed that an increase in chromatid-type aberrations was associated 
specifically with the BALB/c mouse strain, which has been shown to be susceptible to 
mammary carcinogenesis, again providing a vital link between instability and 
carcinogenesis (Ullrich and Davis, 1999). 
To the best of our knowledge, this is the first report of chromatid aberrations, an 
indication of delayed genomic instability, associated with 
56
Fe ion- and ɣ-induced AML. 
On-going instability is significantly increased in IR-induced AML samples versus 
irradiated non-AML samples, suggesting that the instability is specific to AML or cell 
type and not simply a consequence of radiation exposure.  We also showed that the 
observed increase in chromatid-type aberrations is not due to an increase in age of the 
mice.  
 We did not observe a significant difference in aberration frequencies following 
56
Fe versus ɣ-irradiation in the IR-induced AML samples. This result was unexpected 
because 
56 
Fe ions have a greater linear energy transfer (LET) than that of ɣ-irradiation 
from 
137
Cs.  AML induction was not increased in CBA/Ca mice following 
56
Fe ion 
radiation exposure; an RBE of approximately one was observed (Weil et al., 2009). 




as an endpoint (Weil et al., 2009), suggesting that the endpoint may greatly confound the 
estimated RBE.  
 Spleen colonies were evaluated for instability at two time points. The CFU-S 
assay relies on short-term repopulating cells in forming these clonal spleen colonies. The 
presence of colonies containing aberrations at these time points suggest that instability 
develops at early times during leukemogenesis. These results also suggest that some 
genetic changes may occur in these repopulating cells that facilitate propagation of 
instability in the cell progeny. 
 Critical telomere shortening, has been shown to be associated with cancer and 
AML (Finnon et al., 2001; Hartmann et al., 2005; Swiggers et al., 2006). We did not 
observe an increase in telomere-type aberrations in our AML mouse model. However, 
because mouse telomeres are maintained by active telomerase (Chadeneau et al., 1995; 
Prowse et al., 1993), and human telomeres are not, telomere length and function are quite 
different. To further investigate, we analyzed two human AML cell lines, and observed 
an increase in telomere-, chromatid- and chromosome-type aberrations. This overall 
increase in chromosomal instability is suggestive of on-going instability in human AML. 
Interestingly we identified a clonal aberration in the KG-1a AML cell line that involved 
telomeres, suggesting that telomere un-capping contributed to the overall ongoing-
instability. This telomere fusion event was associated with a previously identified 
translocation between chromosomes 5 and 17, t(5;17) [(Mrozek et al., 2003) and personal 
correspondence, Dr. Michelle Le Beau].  Le Beau et al. identified this translocation event 




the involvement of the terminus of chromosome 17. Our results confirmed this suspicion 
and retention of the telomeric ends.  
 Together, our data provide new evidence that instability contributes to radiation-
induced AML in the CBA mouse model following 
56
Fe ion- and ɣ-irradiation and also in 
two human AML cell lines. Interestingly, telomere dysfunction may contribute to the 
instability observed in the KG-1a cell line, a human AML cell line.  
 The significance of genomic instability and cancer was first suggested by Nowell 
in 1976 (Nowell, 1976). Instability may manifest itself as sequence mutations, gene 
amplifications, or chromosomal changes, as we observed here in our studies (Lengauer et 
al., 1998). The underlying cause of instability has been linked to defective cell cycle 
checkpoints (Zhou et al., 1996), the mismatch repair (MMR) pathway (Ionov et al., 1993; 
Thibodeau et al., 1993) and replication fragile sites (Coquelle et al., 1997; Glover et al., 
1998; Glover and Stein, 1987; Ozeri-Galai et al.). Delayed genomic instability, or 
instability observed many generations after irradiation, is more difficult to define. Both 
reactive oxygen species (ROS) (Limoli et al., 2003) and the inflammatory response 
(Lorimore et al., 2001) have been proposed as mechanisms to explain how damage is 
propagated many cell generations later. Although the mechanisms of instability are still 
largely being explored, the link between instability and tumor progression is undeniable 
(Lengauer et al., 1998).  





ion in comparison to ɣ-ray exposure, our results would predict a small if 




instability as an endpoint. More studies are required in order to fully assess and predict 
cancer risk to astronauts in future space travel. 
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Overview 
 The DNA dependent Protein Kinase catalytic subunit (DNA-PKcs) has been 
shown to be essential for effective mammalian telomeric end-capping function, 
specifically of leading-strand telomeres (Bailey et al., 2001; Bailey et al., 1999). 
Interestingly, DNA-PKcs was recently shown to phosphorylate the heterogeneous nuclear 
ribonucleoprotein A1 (hnRNP A1) (Ting et al., 2009; Zhang et al., 2004), an RNA 
binding protein shown to play a role in telomere length and telomerase activity (Zhang et 
al., 2006). hnRNP A1 has also been shown to bind telomere repeat-containing RNA 
(TERRA) (de Silanes et al., 2010), and TERRA has been proposed to help maintain the 
heterochromatic state of telomeres (Deng et al., 2009).  Taken together, we hypothesized 
that DNA-PKcs kinase activity mediated phosphorylation of hnRNP A1 contributes to 
localization of TERRA to telomeres, a sequence of events critical to maintenance of the 
heterochromatic “capped” state of telomeres.  We confirmed that both siRNA depletion 
of DNA-PKcs protein levels and specific inhibition of DNA-PKcs kinase activity 
decreased phosphorylation of hnRNP A1.  However, we did not see a decrease in 
TERRA localization at telomeres following inhibition of DNA-PKcs kinase activity, 
indicating that DNA-PKcs kinase activity is not necessary for maintaining TERRA at 
telomeres. We did observe a decrease in overall TERRA levels, suggesting an indirect 






Telomeres are protective features at the ends of chromosomes that in vertebrates 
are composed of tandem TTAGGG repeats (Blackburn, 1991; Moyzis et al., 1988). 
Telomeres also serve to “cap” the end of chromosomes, primarily through a complex of 
proteins, termed Shelterin (de Lange, 2005). With each round of replication, telomeres 
shorten due to the inherent failure of replication machinery to add sequences at the 5‟ end 
in lagging strand synthesis (Watson, 1972). Telomere length is maintained by telomerase, 
a specialized reverse transciptase, in germ line cells, stem cells and a large proportion of 
tumor cells and is important in bypassing cellular senescence (Chiu et al., 1996; Harley 
and Villeponteau, 1995; Hiyama et al., 1996; Kim et al., 1994; Mantell and Greider, 
1994).   
DNA protein kinase catalytic subunit (DNA-PKcs) together with the Ku70 and 
Ku80 heterodimer form the DNA-PK holoenzyme, an important player in the  Non-
Homologous End Joining (NHEJ) repair pathway (Gottlieb and Jackson, 1993). Loss or 
deficiency of DNA-PKcs results in inefficient repair following double strand break 
(DSB) induction (Okayasu et al., 1998; Okayasu et al., 2000). We have previously shown 
that DNA-PKcs kinase activity is also vital for maintaining telomere end-capping 
function and preventing end-to-end fusion events (Bailey et al., 2001; Bailey et al., 1999).  
We have also found that DNA-PKcs autophosphorylation, specifically at the Thr-2609 
cluster, is important for its role in telomere function (Williams et al., 2009). However, the 
mechanism by which DNA-PKcs contributes to telomere end-capping function remains 
largely unexplored.  
Due to the repetitive nature and heterochromatic structure of telomeres, they have 




telomeres are in fact transcribed into telomere repeat-containing RNA or telomeric RNA 
(TERRA/TelRNA), and this sequence has been shown to be predominantly UUAGGG 
(Azzalin et al., 2007; Schoeftner and Blasco, 2008). TERRA has been proposed to inhibit 
telomerase activity (Schoeftner and Blasco, 2008), help maintain telomeric 
heterochromatin structure (Deng et al., 2009) and form G-quadruplex structures with 
telomeric DNA (Xu et al., 2010; Xu et al., 2009).  
Interestingly, DNA-PKcs has been shown to phosphorylate the RNA binding 
protein, hnRNP A1, in vitro and in vivo (Ting et al., 2009; Zhang et al., 2004). 
Heterogenous nuclear ribonucleoprotein A1 (hnRNP A1) is an abundant RNA binding 
protein important in mRNA shuttling (He and Smith, 2009) and alternative splicing 
(Martinez-Contreras et al., 2007; Mayeda and Krainer, 1992). hnRNP A1 has also been 
shown to play a role in telomere biology; hnRNP A1 binds telomere sequences and 
increases telomerase activity (Zhang et al., 2006). Therefore, we explored the possible 
role of DNA-PKcs mediated phosphorylation of hnRNP A1 on TERRA localization to 
telomeres. We confirmed that siRNA knockdown of DNA-PKcs or kinase inhibition 
decreased phosphorylation of hnRNP A1 in MCF7 cells, a tumorigenic mammary 
epithelial cell line. Decreased phosphorylation was also observed in MCF 10a cells, a 
non-tumorigenic mammary epithelial cell line following siRNA treatment. Because 
hnRNP A1 preferentially binds to UAGGGA/U sequences (Burd and Dreyfuss, 1994; 
Hamilton et al., 1997), a sequence similar to TERRA, we hypothesized that hnRNP A1 
plays a role in the localization of TERRA at telomeres. However, no change in 





 To monitor overall TERRA levels, we performed RNA dot blot experiments 
following DNA-PKcs kinase inhibition. We observed a significant decrease in TERRA 
levels following DNA-PKcs kinase inhibition in the MCF 7 cell line, suggesting DNA-
PKcs kinase activity may have an indirect effect on TERRA levels.  
 
Materials and methods 
Cell culture 
The MCF7 cell line, a gift from Laura Chubb at Colorado State University 
Veterinary Teaching Hospital, was originally derived from a metastatic mammary 
carcinoma and was grown in Minimum Essential Media/Earle‟s Balanced Salt Solution 
(MEM/EBSS; Hyclone) media supplemented with 10% fetal bovine serum (FBS; Sigma).  
The epithelial mammary non-tumorigenic cell line, MCF 10A, was purchased from 
ATCC and cultured in 1:1 Dulbecco‟s Modified Eagle‟s Medium (DMEM) / Ham‟s F12 
growth media (Hyclone) supplemented with 5% FBS , 20ng/ml Epidermal Growth Factor 
(EGF; Sigma), 0.5ug/ml hydrocortisone (Sigma), 0.1ug/ml cholera toxin (Sigma), 
10ug/ml insulin (Sigma), 1% Glutamax (Gibco) and 1% penicillin/streptomycin 
(Hyclone). Cell media was changed every 3-4 days, and cells were passaged 1-2 times 
per week.  
 
RNA Fluorescence In Situ Hybridization (FISH) and Immunocytochemistry (ICC) 
Cells were grown on chamber slides, washed at room temperature with 
cytoskeleton (CSK) buffer for 30 seconds, permeabilized with 0.5% Triton X-100 in 




minutes at room temperature.  Following fixation, slides were blocked in 3% Bovine 
Serum Albumin (BSA) for 1 hour at room temperature.  Slides were then incubated for 1 
hour with mouse anti-Telomere Repeat Factor 2 (TRF2) primary antibody at room 
temperature followed by incubation with anti-mouse Alexa 594 secondary antibody for 
45 minutes.  Slides were  washed once with 1X Phosphate Buffer Saline (PBS), incubated 
overnight with a FITC labeled Peptide Nucleic Acid (PNA) telomere probe (CCCTAA)7 
specific to TERRA and sequentially washed in 50% formamide/2X Saline Sodium 
Citrate (SSC), 2X SSC, 2X SSC/NP-40 for 2.3 min each at 39
0
C.  Lastly, the slides were 
mounted with ProLong Gold Antifade with 4',6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) (Invitrogen). 
 
Microscopy and imaging 
Stacked images were acquired using a Nikon Eclipse E600 epifluorescent 
microscope, and Metamorph software was used for 3-D deconvolution and 
reconstruction.  Colocalization of TERRA and TRF2 signals was established using 
different statistical parameters to measure 3-D images and generate the colocalization 
profile for each particular cell.  Metamorph and Image J software were used to measure 
the colocalization signals from the acquired 3-D images in both channels, green 
(TERRA) and red (TRF2), using colocalization coefficients, including Pearson‟s 







Small interfering (si) RNA of DNA-PKcs 
The reverse transfection method was performed as recommended by the 
Lipofectamine RNAimax manufacter (Invitrogen). Cells were seeded at 50% confluency 
simultaneously treated with lipofectamine alone (mock) or with siRNA oligonucleotide 
and lipofectamine. An untreated control was included to assess effects from 
lipofectamine treatment. Cells were treated with siRNA sense sequence: 
GAUCGCACCUUACUCUGUUdTdT and antisense sequence: 
AACAGAGUAAGGUGCGAUCdTdT (Dharmacon), as previously described (Peng et 
al., 2002), at a final concentration of 25nM. Cells were collected at various time points 
following transfection, and knock down efficiency was evaluated by real-time 
Polymerase Chain Reaction (PCR) and immunoblot analysis. Optimal knockdown of 
DNA-PKcs was achieved at 72 hours, which was subsequently used for all experiments.  
 
DNA-PKcs kinase activity inhibition (NU7026) 
Cells were treated with the specific DNA-PKcs kinase activity inhibitor 2-
(Morpholin-4-yl)-benzo[h]chromen-4-one (NU7026; Sigma), resuspended in Dimethyl 
Sulfoxide (DMSO), at a final concentration of 10nM and incubated for 24 hours. 




P) uptake assay for phosphorylation status 
Cells were rinsed once and incubated with phosphate-free media Dulbecco‟s 
Minimum Essential Media (DMEM; Invitrogen) for 24 hours to deplete adenosine 
triphosphate (ATP) pools. 400µCi of 
32




every 2 mL of media and incubated at 37ºC with 95% O2 and 5% CO2 for 4 hours to 
allow for labeling of ATP pools, as previously described (Ting et al., 2009). Cells were 
subsequently lysed, and total protein amount was quantified via Bradford assay. This was 
followed by immunoprecipitation of hnRNP A1 and Sodium Dodecyl Sulfate Solution 
Polyacrylamide Gel Electrophoresis (SDS-PAGE).  
 
Cell lysis and protein quantification 
Cells were harvested by trypsinization and pellets were washed with 1X PBS. 
Pellets were subsequently incubated in lysis buffer for 10 minutes over ice with periodic 
mixing. Lysis buffer includes 50mM Tris-HCL, 150mM NaCL,  2 mM 
Ethylenediaminetetraacetic Acid (EDTA), 2mM Ethylene Glycol Tetraacetic Acid 
(EGTA), 25mM NaF, 25mM β-glycerophosphate, 0.2% triton x-100, 0.3% NP-40, and  
0.1mM sodium ortho-vanadate in water. Protease inhibitors were added directly before 
use, including 0.1mM Phenylmethylsulfonyl Fluoride (PMSF), 5μg/mL leupeptin and 
5μg/mL aprotinin. For phosphorylation experiments, cells were rinsed and lysed in the 
tissue culture flask over ice for 10 minutes with lysis buffer and Halt Phosphatase 
inhibitors (Pierce). The Bradford Assay was used to quantify total protein amounts in 
whole cell lysates using Bradford Dye (Bio-Rad).  
 
Immunoprecipitation of hnRNP A1 and SDS-PAGE  
Immunoprecipitations were performed using the Direct IP kit (Pierce), as 
recommended by the manufacturer. Whole cell lysates were precleared by incubating 




first incubating antibody with resin on a column. Approximately, 1000μg of protein was 
incubated with 50μg of antibody against hnRNP A1 (Abcam ab5832 clone 9H10) or IgG 
control (R & D Systems MAB004) for 1 hour with rotation at room temperature. Samples 
were acetone precipitated, subsequently examined by SDS-PAGE and transferred to a 
Polyvinylidene Fluoride (PVDF) membrane using a semi-dry transfer method. Transfer 
was performed at 15V for 1 hour and 15 minutes.  The membrane was marked with 
diluted 
32
P and coomassie dye in order to orient the images and then exposed to a 
phosphor imaging screen (Kodak) for 48 hours. The screen was imaged on a Storm 860 
(GE Healthcare) and quantified using Image Quant (GE Healthcare) software. The same 
membrane was rewetted and probed for total amounts of hnRNP A1 via immunoblotting.  
 
Immunoblotting 
 Protein samples were separated via SDS-PAGE and transferred to a methanol 
activated polyvinylidene fluoride (PVDF) membrane. The membrane was blocked for 1 
hour with 4% powdered milk in Tris-buffered saline with 0.1% Tween (TBST) at room 
temperature with shaking and rinsed once in TBST before incubating with primary 
antibody in 1% milk in TBST for 1 hour at room temperature or overnight at 4ºC with 
shaking. Primary antibody dilutions included hnRNP A1 (Abcam ab5832 clone 9H10) at 
a 1:1000 concentration, β-tubulin (Abcam ab6046) at a 1:1000 concentration, DNA-PKcs 
(NeoMarkers MS-423-P) at a 1:40 concentration and Actin (Abcam Ab3280) at 1:1000. 
The membrane was subsequently washed 4 times in 1X TBST for 5 minutes each at room 
temperature with shaking, incubated with secondary antibody in Licor Blocking Buffer 




washes as above. Alexa Fluor 680 (Invitrogen A21058) and goat anti-rabbit IgG 800 
(Thermo Scientific 35571) secondary antibodies were added at a 1:10,000 and 1:40,000 
dilution respectively. Lastly, the membrane was imaged on the Odyssey Imaging System 
(Licor). Relative protein expression was measured as a ratio of the intensity of the bands 
using Odyssey imaging software, while accounting for background.  
 
Real-time Polymerase Chain Reaction (PCR) 
 Total RNA was harvested from untreated, mock treated and siRNA treated 
samples using the Qiagen RNeasy kit (Qiagen). RNA was quantified using a Nanodrop 
Spectrophotometer and reverse transcribed using the Verso cDNA kit (Thermo 
Scientific). Real-time PCR was performed using SYBR green (Thermo Scientific) 
according to manufacter‟s protocol and performed using a Bio-Rad iCycler IQ. The real 
time cycle was as follows: Cycle 1 at 95ºC for 15 minutes, cycle 2 (40X) step 1 at 95ºC 
for 15 seconds, step 2 at 59ºC for 30 seconds and step 3 at 72ºC for 30 seconds.  A melt 
curve was included to assess primer dimers and non-specific amplication as follows: 
cycle 3 at 95ºC for 30 seconds, cycle 4 at 55ºc for 30 seconds and cycle 5 (80X) at 55ºC 
for 10 seconds. Primer for amplification of human DNA-PKcs (Sigma) was added at a 
final concentration of 300nM including a forward sequence: 
AGCAATGCACCGTTGTGGT and reverse sequence: TCCTTCTTCAGGAGCTTCCA. 
Primers for amplification of transferrin receptor (TFRC) at a final concentration of 
300nM were included as a housekeeping gene with the forward sequence: 









RNA dot blot 
RNA dot blots were performed as previously described with some modifications 
(Kafatos et al., 1979). Total RNA extraction was accomplished using a Qiagen RNeasy 
kit (Qiagen), and RNA quality was assessed by gel electrophoresis. Pre-wet GeneScreen 
Plus Nylon (Perkin Elmer) and Bio-Dot SF filter paper (Biorad) in 20X SSC was 
assembled into a Bio-rad biodot apparatus that could be attached to a vacuum source. The 
membrane was rinsed twice in 10X SSC. 7.5ug of RNA was diluted in ddH20 with 30µL 
of RNA denaturing solution (66% formamide, 21% Formaldehyde [37%], 13% 10X 
MOPs pH 7). RNA was denatured for 5 minutes at 75ºC, and then an equal volume of 
20X SSC was added. Samples were subsequently applied to the slots, drawn onto the 
membrane by vacuum and washed twice with 10X SSC. Vacuum was applied for 5 
minutes to dry the membrane. The membrane was then removed and UV irradiated in the 
UV Stratalinker 2400 (Stratagene) for 25-50 seconds. The membrane was stained in 
0.02% Methylene blue, 0.5M Sodium Acetate, pH 5.2 in order to visualize and mark 
RNA dots. Hybridization solution (2mM vanadyl, 50% formamide, 30% 20xSSC, 1% 
50X Denhardt‟s solution, 0.25% SDS [20%], 0.1 % or 250ug/mL of salmon sperm DNA, 
brought up to volume with ddH20) was incubated with the membrane for 2 hours at 42ºC. 
Fresh hybridization buffer was added containing denatured PNA FITC labeled TERRA 
probe (CCCTAA)7 and denatured FITC labeled-GAPDH PNA probe (DAKO) and then 




SSC at room temperature for 10 minutes each; 2) 2 times in 0.1X SSC 2, 0.1% SDS at 
50ºC for 30 minutes each; and 3) 2 times in 0.1X SSC, 0.5% SDS at 68ºC for 30 minutes 
each. Imaging was performed on a Storm 860 (GE Healthcare) and image analysis was 
done using Image J (National Institute of Health; NIH). 
 
Results 
siRNA silencing of DNA-PKcs 
 In order to confirm DNA-PKcs dependent phosphorylation of hnRNP A1 in our 
cell lines, we used two approaches, siRNA DNA-PKcs protein depletion and kinase 
activity inhibition. For the first approach, we decreased DNA-PKcs protein expression by 
siRNA transfection, and then assessed efficiency of knockdown of both mRNA and 
protein via real-time PCR analysis and immunoblotting (Figure 3.1). DNA-PKcs mRNA 
expression was compared to the housekeeping gene, Transferrin Receptor (TFRC), and 
DNA-PKcs protein expression was compared to actin. Relative protein expression of 
DNA-PKcs was comparable between MCF 10a and MCF7 cells at 1.66 + 0.66 and 2.20 + 
0.58 respectively, determined from four independent protein isolations and two 
immunoblots per isolation (data not shown).  Decreased mRNA levels were seen as early 
as 24 hours after siRNA addition, and optimal protein knockdown was achieved at 72 
hours (Figure 3.1 and Figure 3.2). 
 
DNA-PKcs phosphorylation of hnRNP A1  
 DNA-PKcs dependent in vivo phosphorylation of hnRNP A1 has previously been 
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Figure 3.1. Time course and efficiency of siRNA depletion of DNA-PKcs in MCF 
10a cell line. A) Relative mRNA expression of DNA-PKcs in mock (M) and 
siRNA treated (S) as compared to the housekeeping gene (TFRC) over time using 
real-time PCR analysis and the 2
-∆∆CT 
method. DNA-PKcs mRNA expression was 
decreased as early as 24 hours following siRNA treatment (gray) when compared 
to mock treated (blue). DNA-PKcs mRNA levels fully recovered by 240 hours 
post siRNA treatment. B) Immunoblot analysis shows decreased DNA-PKcs 
(460kDa) protein levels as early as 48 hours post siRNA treatment (S) when 
compared to mock (M) or untreated (U) samples. Actin (42kDa) was used as a 
loading control. Time zero (T0) was included in each immunoblot. Optimal 
protein knockdown was observed at 72 hours post transfection, and protein levels 
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Figure 3.2. Time course and efficiency of silencing of DNA-PKcs in the 
MCF7 cell line. A) Relative mRNA expression of DNA-PKcs in mock 
(M) and siRNA treated (S) in comparison to the housekeeping gene 
(TFRC) using real-time PCR and the 2
-∆∆CT 
method. Decreased DNA-
PKcs mRNA expression was seen as early as 24 hours post siRNA 
treatment (green) as compared to mock treatment (purple). DNA-PKcs 
mRNA levels were almost fully recovered by 240 hours post siRNA 
transfection. B) DNA-PKcs (460kDa) protein levels were monitored via 
immunoblotting, protein was decreased by 48 hours and optimally 
decreased by 72 hours post siRNA treatment. Time zero (T0) was 
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DNA- PKcs in our human mammary epithelial cells, we assessed 
32
P uptake following 
either siRNA silencing of DNA-PKcs protein or the specific inhibition of DNA-PKcs 
kinase activity with NU7026 (Hollick et al., 2003).  Protein was harvested at 72 hours 
post siRNA transfection or 24 hours post kinase activity inhibition (NU7026), and 
hnRNP A1 was immunoprecipitated (IP). Following IP, SDS-PAGE was performed, 
protein was transferred to a PVDF membrane, which was then exposed to a phosphor 
screen for 48 hours before scanning on a Storm imager. Decreased 
32
P uptake following 
siRNA depletion of DNA-PKcs was observed in both MCF 10a and MCF7 cell lines 
(Figure 3.3). A decrease in 
32
P uptake was also seen following DNA-PKcs kinase 
inhibition in MCF7 cells. However, a decrease in 
32
P uptake following inhibitor treatment 
in MCF 10a cells was not seen. These results may be partly explained by the different 
levels of human telomerase RNA component (hTR) in the two cell lines, as hTR 
influences the specific phosphorylation of hnRNP A1 by DNA-PKcs (Ting et al., 2009). 
hTR levels, as well as telomerase activity, have been shown to be decreased in MCF 10a 
in comparison to MCF7 (Ramachandran et al., 2002). Furthermore, decreased 
32
P uptake 
following siRNA knockdown of DNA-PKcs may be due to indirect effects on other 
kinases, as the depletion or defiency in DNA-PKcs has been shown to also affect the 
levels of ATM (Peng et al., 2005). ATM and DNA-PKcs have been shown to share many 
phosphorylation targets, including ɣH2AX (Wang et al., 2005) and Replication Protein A 
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Figure 3.3. DNA-PKcs dependent phosphorylation of hnRNP A1. A) 
32
P 
uptake in MCF7 cell line, relative to total intensity of protein by 
immunoblotting and Odyssey imaging. Decreased uptake was seen 
following both siRNA silencing of DNA-PKcs (~40%) and kinase activity 
inhibition (~70%). Untreated samples were comparable to that of mock 
and DMSO treated cells.  B) 
32
P uptake in MCF 10a cell lines. A decrease 
was observed following siRNA. We observed a difference between 
untreated and mock sample versus previous runs, suggesting slightly more 
variation in this sample. No decrease in hnRNP A1 phosphorylation was 
observed following DNA-PKcs kinase activity inhibition, suggesting that 
DNA-PKcs does not play a large role in phosphorylating hnRNP A1 in the 




TERRA localization at telomeres following inhibition of DNA-PKcs kinase activity 
 Because deficient levels of DNA-PKcs, as well as siRNA knockdown of DNA-
PKcs,  has been shown to also reduce the levels of ATM (Peng et al., 2005), we treated 
cells with a specific DNA-PKcs kinase activity inhibitor (NU7026) to evaluate TERRA 
localization at telomeres. Having confirmed that NU7026 treatment decreased 
phosphorylation of hnRNP A1 in the MCF7 cell line, we repeated the treatment and 
analyzed the effects of DNA-PKcs kinase activity inhibition on TERRA localization at 
telomeres. We performed RNA FISH using a probe specific to TERRA in conjunction 
with immunocytochemistry using an antibody against TRF2, a telomere specific protein. 
We analyzed 38 cells per treatment type. Using a novel 3-D imaging and reconstruction 
technique, significant changes in TERRA colocalization with TRF2 following NU7026 
treatment in MCF7 cells were not observed, suggesting that loss of DNA-PKcs kinase 
activity does not affect TERRA localization at telomeres (Figure 3.4 and Figure 3.5). 
This was seen both visually when examining the images and also analyzed by applying 
statistical methods. Here, Pearson‟s Correlation Coefficient was used to assess the 
correlation of the two molecules, where a coefficient of 0.69 represents the colocalization 
of the two molecules (Bolte and Cordelieres, 2006). Similar to previous studies, we 
observed that not all cells expressed TERRA (Azzalin et al., 2007; Schoeftner and 
Blasco, 2008). Furthermore, not all telomere ends had TERRA; i.e., red (TRF2) foci were 
often seen alone, while all green (TERRA) foci were seen colocalized with red. In 
essence, all TERRA molecules were observed to be at telomere ends. Interestingly, we 






Figure 3.4. TERRA localization following DNA-PKcs kinase inhibition in 
MCF7. A)  3-D images of TERRA (green) and TRF2 (red) colocalization. 
Every TERRA molecule colocalized (yellow) with a TRF2 molecule. No 
significant decrease in TERRA colocalization with TRF2 was observed 
following NU7026 treatment. B) A shift in colocalization of TRF2 and TERRA 
was seen in a small subset of cells treated with NU7026 resulting in decreased 
overlap of the two molecules. The image on the left depicts what is generally 
seen with a Pearson‟s Coefficient of ~0.69. C) RNase treatment was done as a 
control to confirm that the probe was specific to TERRA. 
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Figure 3.5. A) Scatter plot depicting average Pearson‟s Correlation 
Coefficient per cell in DMSO control in comparison to NU7026 treated. 
The bars depict the mean value of total data, where the mean is slightly 
decreased in NU7026 treated samples (DMSO=0.694, NU7026=0.654), 
and this correlates with a decrease in TERRA and TRF2 foci overlap in a 
small subset of the colocalized foci. 




appeared differentially spaced, and this was slightly increased following DNA-PKcs 
kinase inhibition. Specifically, TERRA and TRF2 were colocalized but appeared to 
overlap to a lesser degree following NU7026 treatment, suggesting a shift in their 
interaction following DNA-PKcs kinase inhibition (Figure 3.4). This was visually 
observed when Pearson‟s Correlation Coefficient was ~0.4. We, therefore, grouped the 
data into two categories, with one including Pearson‟s Correlation Coefficient that fell at 
or above 0.5 and the other with those that fell below. For DMSO control, 5.3 % of cells 
scored had an average Pearson‟s Correlation Coefficient that fell below 0.5, while 7.9 % 
or NU7026 treated cells had an average Pearson‟s Correlation Coefficient that fell below 
this number. Furthermore, this shift is also reflected by a lower overall mean for 
Pearson‟s Coefficient when all data was combined (Figure 3.4 and Figure 3.5).   
 
DNA-PKcs influences TERRA levels 
In order to assess the contribution of DNA-PKcs kinase activity on TERRA 
levels, we performed RNA dot blots on total RNA following 24 hour NU7026 inhibitor 
treatment in both MCF7 and MCF 10a cells. Three independent experiments were 
performed. TERRA levels in the MCF 10a cell line were sensitive to Dimethyl Sulfoxide  
 (DMSO) treatment, as a decrease in TERRA was observed with both DMSO alone or 
with NU7026, resuspended in DMSO (Figure 3.6). This result could be due to changes in 
cell growth or cell cycle, as TERRA levels have been shown to vary with cell cycle 
phases (Flynn et al., 2011; Porro et al.). However, no significant change in TERRA level 
was observed between the DMSO control and NU7026 treated samples, suggesting 
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Figure 3.6. TERRA RNA levels evaluated via RNA dot blot following 
DNA-PKcs kinase inhibition (NU7026). A) RNA dot blots were used to 
evaluate TERRA levels relative to a housekeeping gene (GAPDH). 
TERRA levels were analyzed in untreated (UT), DMSO control or 
following the treatment with the DNA-PKcs kinase inhibitor, NU7026. 
RNase treatment confirms that probe is specific to RNA. B) TERRA 
levels in MCF 10a cells appear to be sensitive to DMSO treatment. No 
significant change in TERRA levels relative to GAPDH was seen 
following NU7026 treatment in comparison to DMSO control. A 
significant (p=0.037) decrease in TERRA level was observed following 










10a cell line. However, a significant decrease (p=0.037) in TERRA levels was observed 
following NU7026 treatment in the MCF7 cell line when compared to the DMSO control. 
This suggests that DNA-PKcs kinase inhibition indirectly affected TERRA levels.  
 
Discussion 
 We have shown that DNA-PKcs kinase activity plays an important role in 
mammalian telomere end-capping function (Bailey et al., 2001; Bailey et al., 1999). 
However, the mechanism by which DNA-PKcs operates to cap telomeres is largely 
unknown. Here, we explored a possible interaction between DNA-PKcs and TERRA.  
We hypothesized that DNA-PKcs dependent changes in TERRA localization at 
telomeres may be mediated through hnRNP A1, as hnRNP A1  has been shown to be  a 
phosphorylation target of DNA-PKcs (Ting et al., 2009; Zhang et al., 2004) and to play a 
role in telomere biology (Zhang et al., 2006). We confirmed that DNA-PKcs targets 
hnRNP A1 for phosphorylation by analyzing 
32
P uptake following siRNA depletion of 
DNA-PKcs or kinase inhibition. We found decreased hnRNP A1 phosphorylation 
following siRNA depletion of DNA-PKcs in both MCF7 and MCF 10a cell lines. 
However, decreased hnRNP A1 phosphorylation was not observed in the MCF 10a cell 
line following NU7026 treatment, suggesting hnRNP A1 phosphorylation in MCF 10a 
cells was not DNA-PKcs dependent. This may be due to the reduced hTR status of MCF 
10a cells (Ting et al., 2009); a previous study demonstrated decreased hTR levels in MCF 
10a cells (Ramachandran et al., 2002). The observed decrease in 
32
P uptake following 
siRNA depletion of DNA-PKcs in the MCF 10a cell line may reflect the indirect effects 
of siRNA transfection, such as concomitant decreases in ATM kinase protein (Peng et al., 




phosphorylation of hnRNP A1 is dependent on hTR expression (Ting et al., 2009). 
Furthermore, other kinases are likely involved in hnRNP A1 phosphorylation, as 
32
P 
uptake was still observed in hnRNP A1 immunoprecipitates with inhibition of DNA-
PKcs kinase activity. Other candidate kinases include p38 MAP kinase (Shimada et al., 
2009), protein kinase A (Cobianchi et al., 1993), casein kinase (Gao et al., 2000) and 
protein kinase C (Municio et al., 1995).   
Inhibition of DNA-PKcs kinase activity did not significantly influence TERRA 
localization at telomeres, implying that DNA-PKcs does not participate in keeping 
TERRA at telomere ends.  However, 3-D imaging revealed a shift in TRF2 and TERRA 
distribution within colocalized foci, suggesting changes may be occurring at individual 
telomeres, where loss of DNA-PKcs influences the interaction between TRF2 and 
TERRA.  Alternatively, DNA-PKcs kinase inhibition may affect the telomeric 
heterochromatin structure. Such instances might occur during repair, for example repair 
of oxidative damage or during replication, where individual telomeres respond 
independently. TERRA has been shown to inhibit telomerase activity  by binding the 
telomerase RNA template itself (Schoeftner and Blasco, 2008) or by hindering access to 
telomerase by forming a G-quadruplex structures on telomere ends (Xu et al., 2010; Xu et 
al., 2009). Interestingly, TERRA has also been implicated in heterochromatin 
maintenance at telomere ends (Deng et al., 2009). It is tempting to postulate that one of 
the mechanisms by which DNA-PKcs functions to cap telomeres is through an interaction 
TERRA, where TERRA acts by regulating heterochromatin status. However, this change 
was minor and preliminary; more research is required in order to speculate on this. 




drawn. For example, cells in early S-phase naturally experience changes in 
heterochromatin status.  
We observed a significant decrease in TERRA levels following inhibition of 
DNA-PKcs kinase activity in the MCF7 mammary epithelial cell line, suggesting that 
DNA-PKcs may indirectly affect TERRA levels.  Just how DNA-PKcs functions to affect 
TERRA levels needs further exploration. DNA-PKcs has been linked to transcription 
(Chibazakura et al., 1997; Peterson et al., 1992; Peterson et al., 1995; Sheppard and Liu, 
2000) and has also been shown to phosphorylate RNA polymerase II (Dvir et al., 1992). 
Previous studies have found that RNA polymerase II is partly responsible for 
transcription of TERRA (Azzalin et al., 2007; Schoeftner and Blasco, 2008), providing 
one possible explanation for the decrease in TERRA levels following DNA-PKcs kinase 
inhibition. However, decreased TERRA levels were not observed in the MCF 10a cell 
line. This finding may be attributed to the differing characteristics between the non-
tumorigenic MCF 10a and tumorigenic MCF 7 cell lines, including increased cell growth 
and thus transcription rate in the MCF 7 cell line.  
Other transcription factors have also been shown to be phosphorylated by DNA-
PKcs, including the TATA-binding protein and transcription factor IIB (Chibazakura et 
al., 1997), c-jun (Bannister et al., 1993), c-myc (Iijima et al., 1992) and FOS (Abate et al., 
1993). Although the function of this phosphorylation is still largely unknown, such 
observations do support a role for DNA-PKcs kinase activity in the regulation of 
transcription. 
Another possible explanation for decreased TERRA levels in the MCF7 cell line 




evidence for the DNA-PKcs dependent phosphorylation of hnRNP A1 in the MCF 7 cell 
line; a similar effect was not seen in the MCF 10a cell line. Previously, de Silanes 
observed increased TERRA levels following the inhibition of various hnRNPs, 
specifically hnRNP F (de Silanes et al., 2010). This study suggested that this may be due 
to the role of hnRNP F in pre-mRNA cleavage, where loss of hnRNP F leads to an 
accumulation of TERRA. Similarly, we suggest that the decreased TERRA levels 
following DNA-PKcs kinase inhibition may partly be due to the role of hnRNP A1 in 
pre-mRNA processing. Increased hnRNP A1 phosphorylation has been reported when 
cells undergo stress, and this phosphorylation has been shown to lead to the accumulation 
of hnRNP A1 in the cytoplasm (Allemand et al., 2005; Guil et al., 2006; van der Houven 
van Oordt et al., 2000). Therefore, phosphorylation of hnRNP A1 may act as a switch in 
the cellular distribution of hnRNP A1, such that in a hypophosphorylated state, hnRNP 
A1 remains in the nucleus, where it is most often observed. Assuming there is a basal 
level of hnRNP A1 phosphorylation when cells are not stressed, as our 
32
P data suggests, 
inhibition of DNA-PKcs kinase activity potentially results in increasesd hnRNP A1 
accumulation in the nucleus thus increasing the opportunity for hnRNP A1 and TERRA 
interaction. This would then lead to a decrease in TERRA levels due to the role of 
hnRNP A1 in pre-mRNA cleavage.  Because existing studies suggest a specific 
phosphorylation site for the cytoplasmic accumulation of hnRNP A1, termed the F-
peptide, and this site does not correlate with the proposed hnRNP A1 phosphorylation 
site by DNA-PKcs, we favor an alternative explanation (Allemand et al., 2005; Ting et 
al., 2009). An independent study found decreased hnRNP A1 interaction with Tumor 




map kinase signaling (Buxade et al., 2005). This suggests that phosphorylation may 
affect the ability of hnRNP A1 to interact with its target RNA. Furthermore, Serine 192 
(Ser192) was identified as one of the phosphorylation sites by map kinase signaling-
integrating kinases (MNK), a site shared by DNA-PKcs (Buxade et al., 2005; Ting et al., 
2009). Taken together, decreased TERRA levels following DNA-PKcs kinase inhibition, 
specifically in the MCF7 cell line, may reflect a combination of decreased RNA 
polymerase II transcription and decreased TERRA/hnRNP A1 interaction.  
Taken together, we demonstrate that DNA-PKcs kinase activity does not 
influence TERRA localization to telomeres. We provide evidence that DNA-PKcs kinase 
activity affects TERRA levels, and this may be partly due to the involvement of DNA-
PKcs in transcription regulation as well as the DNA-PKcs dependent phosphorylation of 
hnRNP A1. Determining the exact mechanism of DNA-PKcs kinase activity on TERRA 
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Overview 
Telomeres are highly repetitive features that serve to protect the ends of linear 
chromosomes, which have been regarded as transcriptionally silent until recently.  
Telomeres are transcribed into telomere repeat-containing RNA (TERRA) (Azzalin et al., 
2007; Schoeftner and Blasco, 2008), and TERRA serves to help maintain the condensed, 
heterochromatic state of telomeres (Deng et al., 2009). The RNA binding protein, 
heterogeneous nuclear ribonucleoprotein (hnRNP A1) associates with TERRA (de 
Silanes et al., 2010). hnRNP A1  has also been shown to bind telomeric DNA sequences 
and influence telomerase activity (Ford et al., 2002; LaBranche et al., 1998; Zhang et al., 
2006). We examined hnRNP A1 dependence of TERRA localization to telomeres and 
found no connection, demonstrating that hnRNP A1 does not act to “tether” TERRA to 
telomeric DNA.  It has also been suggested that hnRNPs influence TERRA stability. 
Therefore, we examined TERRA levels using RNA dot blots. We observed no significant 
changes in TERRA levels following siRNA depletion of hnRNP A1. Following siRNA 
depletion of hnRNP  A1 in human mammary epithelial cells, we also investigated 
telomere function and observed increased frequencies of what has previously been 
termed “fragile” telomeres (Sfeir et al., 2009) and telomere sister chromatid exchanges 
(T-SCE), suggesting a role for hnRNP A1 in facilitating telomere replication. Our results 
provide important insights into the roles of the RNA binding protein, hnRNP A1, in 






Telomeres are repetitive, well conserved G-rich TTAGGG repeats at the ends of 
chromosomes in vertebrates (Moyzis et al., 1988). Functional telomeres solve both the 
end-protection problem by preventing fusions (McClintock, 1939) and protecting from 
loss of genetic information (Watson, 1972). Because they are heterochromatic and 
repetitive, telomeres have long been thought to be transcriptionally silent. However, 
telomeres have recently been shown to be transcribed into UUAGGG sequences (Azzalin 
et al., 2007), partly by RNA polymerase II (Schoeftner and Blasco, 2008). Telomeric 
repeat-containing RNA (TERRA) or telomeric RNA (TelRNA), has been shown to 
localize to telomere ends and is associated with heterochromatin maintenance, telomerase 
activity and G-quadruplex formation (Azzalin et al., 2007; Deng et al., 2009; Schoeftner 
and Blasco, 2008; Xu et al., 2010; Xu et al., 2009). TERRA  has been shown to be 
conserved in yeast and partly regulated by suppressors with morphogenetic defects in 
genitalia (SMG) proteins (Azzalin et al., 2007). SMG proteins are important in nonsense-
mediated mRNA decay (NMD) in caenorhabditis elegans (Anders et al., 2003; Page et 
al., 1999). Furthermore,  EST1a, EST1b and EST1c, the human orthologues of SMG 
proteins in C. elegans (Chiu et al., 2003; Gatfield et al., 2003) have been shown to 
interact with telomerase (Reichenbach et al., 2003). In humans, CpG island rich 
promoters have been shown to influence TERRA transcription (Schoeftner and Blasco, 
2008; Yehezkel et al., 2008). TERRA function and how it is maintained at telomeres are 
currently areas of intense investigation. 
 Heterogenous nuclear ribonucleoprotein A1 (hnRNP A1) is a member of a large 




hnRNP A1-U, some of which bind pre-mRNA and packages them for transport (He et al., 
2005).  hnRNPs have also been shown to play a role in mRNA alternative splicing  
(Martinez-Contreras et al., 2007; Mayeda and Krainer, 1992).  hnRNP A1 is one of the 
most abundant proteins in this family (Beyer et al., 1977) and has been shown to bind 
telomeric repeats and influence telomerase activity (Dallaire et al., 2000; LaBranche et 
al., 1998; Zhang et al., 2006).  It has been shown to preferentially bind UAGGGA/U 
sequences, a sequence similar to that of TERRA (Burd and Dreyfuss, 1994; Hamilton et 
al., 1997). In addition, recent studies suggest that hnRNP A1 interacts with TERRA (de 
Silanes et al., 2010; Deng et al., 2009).  
 Telomeres are known to be inherently difficult to replicate due to their highly 
repetitive sequence and propensity to form secondary structures, including G-quadruplex 
structure. Thus, replication fork stalling has been shown to naturally occur at telomeres 
and is exacerbated when lacking the necessary helicases (Ivessa et al., 2002; Ivessa et al., 
2000; Makovets et al., 2004). A recent study demonstrated that Telomere Repeat Factor 1 
(TRF1) was required to prevent the “fragile” telomere phenotype, an extended or doublet 
telomeric signal when using Fluorescence In Situ Hybridization (FISH) with a telomere 
specific probe (Sfeir et al., 2009). This study also provided evidence suggesting that 
“fragile” telomeres were the result of aberrant telomere replication.  
We hypothesized that hnRNP A1 may contribute to “tethering” TERRA to 
telomere ends. We examined such a possibility following siRNA depletion of hnRNP A1 
in two human mammary epithelial cell lines, non-tumorigenic MCF 10a and tumorigenic 
MCF7 cell lines. In conjunction, we utilized RNA FISH with a probe specific for TERRA 




telomere specific protein. We found little to no change in localization of TERRA to 
telomeres following siRNA depletion of hnRNP A1, suggesting that hnRNP A1 does not 
function to “tether” TERRA to telomeres. Because hnRNPs have also been shown to 
influence TERRA stability (de Silanes et al., 2010), we also monitored changes in 
TERRA levels following hnRNP A1 depletion by RNA dot blot. We found no significant 
changes in TERRA levels following siRNA treatment, suggesting that hnRNP A1 does 
not affect TERRA levels, at least at our time point.  
Because hnRNP A1 has also been tightly linked with telomere lengthening via 
telomerase (Zhang et al., 2006), we further examined telomere function following siRNA 
knockdown of hnRNP A1 using Fluorescence In Situ Hybridization (FISH) and 
Chromosome-Orientation (CO-) FISH with a telomere specific probe. We observed 
increased frequencies of  “fragile” telomeres, as previously described (Sfeir et al., 2009) 
and increased Telomere Sister Chromatid Eschange (T-SCE), approaching significance, 
with loss of hnRNP A1. These results suggest a role for hnRNP A1 in facilitating 
telomere replication.  
 
Materials and methods 
Cell culture 
The MCF7 cell line, a gift from Laura Chubb at Colorado State University 
Veterinary Teaching Hospital, was originally derived from a human metastatic mammary 
carcinoma and grown in Minimum Essential Media/Earle‟s Balanced Salt Solution 
(MEM/EBSS; Hyclone) media supplemented with 10% fetal bovine serum (FBS; Sigma).  




ATCC and cultured in 1:1 Dulbecco‟s Modified Eagle‟s Medium (DMEM) / Ham‟s F12 
growth media (Hyclone) supplemented with 5% FBS , 20ng/ml Epidermal Growth Factor 
(EGF; Sigma), 0.5ug/ml hydrocortisone (Sigma), 0.1ug/ml cholera toxin (Sigma), 
10ug/ml insulin (Sigma), 1% Glutamax (Gibco) and 1% penicillin/streptomycin 
(Hyclone). The normal human foreskin fibroblasts, BJ 1, were maintained in high glucose 
DMEM (Gibco) with 10% FBS and 1% penicillin/streptomycin. The isogenic BJ-hTERT 
cell line, parental BJ 1 transfected with the catalytic subunit of telomerase, was 
maintained in α-MEM (Gibco) supplemented with 10% FBS, 1% glutamax 1% 
pennicillin/streptomycin. Both BJ 1 and BJ-hTERT were generous gifts from Dr. Jerry 
Shay at the University of Texas Southwestern Medical Center in Dallas, TX. Normal 
human fibroblasts, 5C, were bought from Cascade Biologicals and maintained in α-MEM 
with 10% FBS, 1% glutamax 1% pennicillin/streptomycin. Cell media was changed 
every 3-4 days, and cells were passaged 1-2 times per week.  
 
Fluorescence In Situ Hybridization (FISH) and two-color Chromosome-Orientation (CO-
) FISH 
Metaphase spreads were collected using standard cytogenetic techniques 
(Henegariu et al., 2001). Briefly, cells were incubated with 0.1ug/mL colcemid, harvested 
and lysed with 75mM KCL, fixed in 3:1 methanol: acetic acid and added to pre-cleaned 
slides. Slides were fixed in 3% paraformaldehyde, dehydrated in an ethanol series (75%, 
85% and 100%) and denatured in 70% formamide/2x saline sodium citrate (SSC) at 70ºC 
for 2 minutes. A G-rich telomere Peptide Nucleic Acid (PNA) probe (TTAGGG)7 




minutes, and for CO-Fish the C-rich telomere probe (CCCTAA)7 labelled with FITC was 
also hybridized onto the slide at 37ºC overnight. Slides were then washed in 50% 
formamide/2xSSC, 2X SSC and 0.1% NP-40/2X SSC at 43ºC for 2.5 minutes each. 
Lastly, slides were mounted in Prolong Gold Antifade (Invitrogen) with 4',6-diamidino-
2-phenylindole, dihydrochloride (DAPI).  
For CO-FISH, in addition to the steps described above, cells were also incubated 
for a single round of replication in 5-bromo-2'-deoxyuridine and 5-bromo-2'-deoxy- 
cytosine (BrdU/BrdC) at a 3:1 ratio for a final concentration of 5 x 10
-5
M. Prior to 
denaturing, slides were stained with Hoescht 33258 (0.5ug/mL), exposed to Ultraviolet 
(UV) light using Stratagene Stratalinker outfitted with 365nM bulbs for 35 minutes, and 
then incubated with Exonuclease III (~10U) for 20 minutes at 25ºC. Lastly, slides were 
hybridized with telomere probes as described above. Three independent experiments 
were performed and 30 metaphases scored per experiment. Because there was no 
significant difference between the individual means, experimental data were combined 
for statistical analysis. Immunoblotting was done to confirm siRNA depletion of hnRNP 
A1 for each experiment. Statistical analysis was done using the student T-test.  
 
Chromosome and telomere aberration scoring criteria 
 Clonal chromosome-type aberrations were not included in the final aberration 
frequencies. Chromatid-type gaps were defined as discontinuities in DAPI staining 
greater than the width of a chromatid arm. Chromatid-type breaks were defined as a 




Telomere function was evaluated using several endpoints. Signal free ends (SFE) 
were assessed following both FISH and CO-FISH using two scoring criteria. First, SFEs 
were scored as a complete lack of telomere signal on one chromatid arm. Secondly, SFEs 
were scored as a single event only if the signal was missing from both sister chromatid 
arms, as would be expected with telomere shortening and subsequent replication. 
“Fragile” telomeres were defined as one extended telomere signal and/or duplicated 
telomere signals. Scoring criteria included that the duplicate telomere signals were within 
one signal width of each other. All signals that did not meet this criterion were 
subsequently scored as interstitial telomere signals (ITS) and were not included as a 
“fragile” telomere.   
 
RNA FISH and Immunocytochemistry (ICC) 
Cells grown on chamber slides were washed at room temperature with 
cytoskeleton (CSK) buffer for 30 seconds, permeabilized with 0.5% Triton X-100 in 
CSK/vanadyl for 5 minutes and subsequently fixed in 3% paraformaldehyde for 10 
minutes at room temperature.  Following fixation, slides were blocked in 3% Bovine 
Serum Albumin (BSA) for 1 hour at room temperature.  Slides were then incubated for 1 
hour with mouse anti-TRF-2 primary antibody (Imgenex) at room temperature followed 
by incubation with anti-mouse Alexa 594 secondary antibody (Invitrogen) for 45 
minutes.  Slides were  washed once with 1X Phosphate Buffer Saline (PBS), incubated 
overnight with a FITC labeled PNA probe (CCCTAA)7 complementary to TERRA and 






C.  Lastly, slides were mounted with ProLong Gold Antifade with DAPI 
(Invitrogen). 
 
Microscopy and imaging 
A Nikon Eclipse E600 epifluorescent microscope was used to acquire stacked 
images, and Metamorph software was used for 3-D deconvolution and reconstruction of 
the acquired images.  Colocalization of TERRA and TRF2 signals was established using 
different statistical parameters to measure 3-D images and generate the colocalization 
profile for each particular cell.  Metamorph and Image J software were used to measure 
the co-localization signals from the acquired 3-D images in both channels, green 
(TERRA) and red (TRF-2), using colocalization coefficients, including Pearson‟s and 
Mander‟s Coefficient.  
 
Small interfering RNA (siRNA) knockdown of hnRNP A1 
 Cells were transfected using the reverse transfection method with lipofectamine 
RNAimax (Invitrogen) as recommended by the manufacturer. Briefly, cells were passed 
and seeded at approximately 50% confluency with non-antibiotic media and were 
simultaneously treated with lipofectamine alone (mock) or lipofectamine and siRNA 
oligonucleotides (siRNA treated) targeted to hnRNP A1. ON-TARGET plus 
SMARTpool siRNA (Dharmacon) oligo sequences used were as follows: 
CGGAAACCUUGGUGUAGUU, GGGAAUGAAGCUUGUGUAU, 
CAACUUCGGUCGUGGAGGA and UAGAAUUCCUUCAGGGUGA. Cells were 




points to monitor knockdown efficiency. Cells were treated with a non-target sequence to 
assess for siRNA specificity to hnRNP A1 using ON-TARGETplus non-targeting pool 
(Dharmacon). siRNA silencing was subsequently confirmed by immunoblotting (below). 
 
Cell lysis and protein quantification 
Cells were harvested by trypsinization and pellets washed with 1X PBS. Pellets 
were subsequently incubated in lysis buffer for 10 minutes over ice with periodic 
flicking. Lysis buffer included 50mM Tris-HCL, 150mM NaCL,  2mM 
ethylenediaminetetraacetic acid (EDTA), 2mM ethylene glycol tetraacetic acid (EGTA), 
25mM NaF, 25mM β-glycerophosphate, 0.2% triton x-100, 0.3% NP-40, and  0.1mM 
sodium ortho-vanadate in water. Protease inhibitors were added directly before use, 
including 0.1mM phenylmethylsulfonyl fluoride (PMSF), 5μg/mL leupeptin and 5μg/mL 
aprotinin.  The Bradford Assay was used to quantify protein in whole cell lysate using 
Bradford Dye (Bio-Rad).  
 
Immunoblotting 
 Protein samples were separated via Sodium Dodecyl Sulfate Solution 
Polyacrylamide Gel Electrophoresis (SDS-PAGE) and transferred to a methanol activated 
Polyvinylidene Fluoride (PVDF) membrane. The membrane was blocked for 1 hour with 
4% milk in Tris-buffered saline with 0.1% Tween (TBST) at room temperature with 
shaking. Membrane was rinsed once in TBST before incubating with primary antibody in 
1% milk in TBST for 1 hour at room temperature or overnight at 4ºC with shaking. 




concentration, and primary antibody toward β-tubulin (Abcam ab6046) was added at a 
1:1000 concentration and used as a loading control. The membrane was subsequently 
washed 4 times in 1x TBST for 5 minutes each at room temperature with shaking, 
incubated with secondary antibody in Licor Blocking Buffer for 2 hours at room temp 
with shaking and subjugated to the 4 TBST washes as described above. Alexa Fluor 680 
(Invitrogen A21058) and goat anti-rabbit IgG 800 (Thermo Scientific 35571) was added 
at a 1:10,000 and 1:40,000 dilution respectively. Lastly, the membrane was imaged on 
the Odyssey Imaging System. Relative protein expression was measured as a ratio of 
intensity of bands using Odyssey imaging software, which also accounts for background.  
 
RNA dot blot 
RNA dot blot was performed as previously described (Kafatos et al., 1979) with 
some modifications. Total RNA extraction was performed using the Qiagen RNeasy kit 
(Qiagen), and RNA quality was assessed by gel electrophoresis. Pre-wet GeneScreen 
Plus Nylon (Perkin Elmer) and Bio-Dot SF filter paper (Biorad) in 20X SSC was 
assembled into a Biorad biodot apparatus which could be attached to a vacuum source. 
The membrane was rinsed twice in 10X SSC. 7.5ug of RNA was diluted in ddH20 with 
30uL of RNA denaturing solution (66% formamide, 21% Formaldehyde [37%], 13% 
10X MOPs pH 7). RNA was denatured for 5 minutes at 75ºC, and then 20X SSC was 
added at an equal volume. Samples were subsequently applied to the slots, vacuumed 
through and washed twice with 10X SSC. Vacuum was applied for 5 minutes to dry the 
membrane. The membrane was then removed and placed in the UV Stratalinker 2400 




0.5M Sodium Acetate, pH 5.2 in order to visualize and mark RNA dots. Hybridization 
solution (2mM vanadyl, 50% formamide, 30% 20xSSC, 1% 50X Denhardt‟s solution, 
0.25% SDS [20%], 0.1 % or 250ug/mL of salmon sperm DNA, brought up to volume 
with ddH20) was incubated with the membrane for 2hrs at 42ºC. Fresh hybridization 
buffer was added with denatured FITC labeled TERRA PNA probe (CCCTAA)7 or 
denatured FITC labeled-GAPDH PNA probe (DAKO) and incubated overnight at 42ºC. 
The membrane was washed with shaking:  1) 4 times in 2X SSC at room temperature for 
10 minutes each; 2) 2 times in 0.1X SSC 2, 0.1% SDS at 50ºC for 30 minutes each; and 
3) 2 times in 0.1X SSC, 0.5% SDS at 68ºC for 30 minutes each. Images were obtained 
using Storm 860 (GE Healthcare) and image analysis was performed using Image J 
(National Institute of Health; NIH). 
 
Results 
siRNA silencing of hnRNP A1  
Following siRNA transfection, relative protein levels of hnRNP A1 in relation to 
β-tubulin were monitored by immunoblotting in five different cells, including BJ1 human 
fibroblasts, BJ-hTERT, 5C human fibroblasts, MCF 10a and MCF7 cells (Figure 4.1). 
Four independent collections were done and immunoblot analysis repeated twice per 
collection.  hnRNP A1 protein expression was consistently higher in the MCF7 cell line 
in comparison to the other cells, similar to previous reports suggesting increased hnRNP 
A1 expression in cancer cells (Boukakis et al.; Ma et al., 2009). Cells were harvested at 
various time points between 24 and 228 hours to monitor protein levels of hnRNP A1 






Figure 4.1. siRNA silencing of hnRNP A1 results in MCF7 and MCF 10a cell 
lines. A) Baseline relative protein expression of hnRNP A1 (34kDa) to β-tubulin 
(50kDa) in 5 different cell types. Increased expression was consistently observed 
in the MCF7 tumorigenic cell line as compared to the others. Data was collected 
from four independent experiments, and immunoblotting repeated twice per 
experiment. B) Immunoblot depicting siRNA silencing of hnRNP A1 results in 
MCF 10a cells. Decreased hnRNP A1 protein expression was seen as early as 48 
hours post siRNA transfection (S) in comparison to mock (M). Optimal 
knockdown was seen 72-96 hour. A non-target (NT) effect of approximately 
16.6% was seen in this cell line based on 2 independent experiments. C) 
Immunoblot depicting results of siRNA silencing of hnRNP A1 in MCF7 cells. 
Optimal knock down was observed 72-96 hours. A non-targeting effect of 
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between 72-96 hours post treatment (Figure 4.1), and therefore subsequent experiments 
were done at 72 hours.  hnRNP A1 siRNA treatment resulted in   ~90% knockdown 
efficiency (Figure 4.1; H-10). An average of a 16.6% decrease (range 5.5-27%) in the 
MCF 10a cell line and a 3.3% decrease (range -3.6-6.7%) in the MCF7 cell line was seen 
when including a non-target oligonucleotide sequence (Figure 4.1; NT).  
 
hnRNP A1 is not required for TERRA localization at telomeres 
 It has been shown that hnRNP A1 interacts with telomeres (Zhang et al., 2006) 
and binds TERRA (de Silanes et al., 2010). Therefore, we investigated TERRA 
localization at telomeres following siRNA silencing of hnRNP A1. We performed RNA 
FISH with a TERRA specific probe FITC-(CCCTAA)7 and immunocytochemistry with 
an anti-TRF2 antibody, a telomere specific protein. We used a novel 3-dimensional 
imaging system in order to assess colocalization (Figure 4.2). We observed little to no 
change in percent colocalization following siRNA knockdown of hnRNP A1 in MCF7 
cells, suggesting that hnRNP A1 is not essential for TERRA localization to telomeres 
(Figure 4.2). Interestingly, we observed a small subset of foci that contained TRF2 and 
TERRA with differential spacing following siRNA depletion of hnRNP A1; i.e., there 
was less overlap between the TRF2 and TERRA foci in individual colocalized foci. 
Colocalization was observed both visually and by using Pearson‟s Correlation 
Coefficient, which is a statistical measure of the correlation between the two molecules. 
A Pearson‟s Correlation Coefficient of 0.69 is considered to reflect colocalization of the 
two molecules (Bolte and Cordelieres, 2006). Using Pearson‟s Correlation Coefficient, a 







Figure 4.2. TERRA and TRF2 3-D colocalization. A) 3-D images of TERRA (green) 
and TRF2 (red) colocalization. Every TERRA molecule was colocalized with a TRF2 
molecule. No significant change in TERRA localization was seen following siRNA 
depletion of hnRNP A1. B) A decrease in TERRA and TRF2 foci overlap was 
observed in a subset of colocalized foci following siRNA treatment. C) Images 
depicting what is generally observed in a partial colocalization event (left) in 
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therefore, grouped the data into two categories, where data were divided into cells that 
had an average Pearson‟s Correlation Coefficient at or above 0.5 and those below 0.5. In 
the mock treated samples, all cells had an average Pearson‟s Correlation Coefficient at or 
above 0.5. However, following siRNA depletion of hnRNP A1, 7.7% of cells examined 
had Pearson‟s Correlation Coefficients that were below 0.5. Furthermore, this is reflected 
in the lower overall mean of Pearson‟s Correlation Coefficient following siRNA 
depletion of hnRNP A1 when data were combined (Figure 4.3). Taken together, this 
suggests that a minor change/shift may be occurring in heterochromatin structure or 
TERRA and TRF2 interaction at individual telomeres following depletion of hnRNP A1. 
However, this is a very preliminary finding and other factors, including cell cycle 
changes need to be accounted for.  
 
hnRNP A1 does not influence TERRA levels 
 hnRNPs have previously been shown to influence TERRA stability, where siRNA 
silencing of individual hnRNPs increased TERRA levels (de Silanes et al., 2010). To 
determine whether our results were influenced by TERRA stability and/or transcription, 
we examined TERRA levels by RNA dot blot with and without siRNA depletion of 
hnRNP A1. We performed three independent experiments and observed no significant 
difference in TERRA RNA levels with decreased hnRNP A1 protein, suggesting that 
TERRA levels were not influenced by the depletion of hnRNP A1 at our time point 


































TERRA localization at telomeres 
Mock siRNA 
Figure 4.3. A) RNase treatment was done to confirm probe specificity to 
TERRA. B) The average Pearson‟s Correlation Coefficient per cell was 
plotted for mock and hnRNP A1 siRNA treated MCF7 cells. A slight 
decrease in the mean, represented by the horizontal bars, was observed and 
reflects a shift in overlap of TRF2 and TERRA following siRNA depletion 
of hnRNP A1 (right).  
 
   
A. 
 









































l MCF 10a UT 
MCF 10a Mock 





Figure 4.4. No significant change in TERRA levels following siRNA 
depletion of hnRNP A1 using RNA dot blot analysis. A) RNA dot blots 
were done using probes specific to TERRA and GAPDH and imaged 
using Storm imager. RNase treatement was used as a control to show 
probe specifically labeled RNA. B) TERRA levels relative to GAPDH 
housekeeping were averaged from three independent experiments. No 
significant change in TERRA levels was seen between untreated (UT), 




Silencing of hnRNP A1 results in “fragile” telomeres 
 Previous reports suggest a role for hnRNP A1 in telomere lengthening (Zhang et 
al., 2006). To evaluate the role of hnRNP A1 in telomere function, we performed FISH 
following siRNA knockdown of hnRNP A1 in MCF7 and MCF 10a cell lines and scored 
telomere-, chromatid- and chromosomal-type aberrations. A total of three independent 
siRNA transfections and metaphase harvests were performed; immunoblotting analysis 
confirmed efficient knock down of hnRNP A1. The tumorigenic MCF7 cell line 
displayed increased chromatid-type, chromosomal-type aberrations and interstitial 
telomere sequences (ITS) in comparison to the non-tumorigenic MCF 10a cell line (data 
not shown). However, there was no significant increase in these aberration frequencies 
following hnRNP A1 siRNA treatment. Both MCF 10a and MCF7 cell lines exhibited a 
clonal aberration involving telomere-ends, seen as two interstitial telomere sequences 
(Figure 4.5). Most striking was a significant increase in “fragile” telomeres, as previously 
termed (Figure 4.6) (Sfeir et al., 2009). Here we specifically define “fragile” telomeres as 
those that exhibit double telomere signals or one extended (stretched out) signal on a 
single chromatid, where a single punctate signal would normally be seen (Figure 4.5). 
This phenotype is indicative of aberrant telomere replication and implicates hnRNP A1 in 
efficient telomere replication. hnRNP A1 has been associated with increased telomerase 
activity and telomere length (LaBranche et al., 1998; Zhang et al., 2006). However, we 
did not observe an overall increase in signal free ends (SFE) following siRNA silencing 
of hnRNP A1 (data not shown). This may be due to our short time course of siRNA 
depletion, as multiple rounds of replication necessary to visualize telomere shortening 













    
    
Figure 4.5. A) FISH using a G-rich, telomere specific PNA probe in MCF 10a 
and MCF7 metaphases. An increase in “fragile” telomeres was observed 
following siRNA treatment of hnRNP A1 (arrows). B) Examples of “fragile” 
telomeres. These were defined as a doublet signal, also called telomere 
duplications, or one extended signal on a single chromatid. C) Common 
aberrations observed in the MCF7 cell line. Aberrations include a clonal single 
interstitial telomere sequence on both chromatid arms, two clonal interstitial 










Figure 4.6. A) Increased frequency of “fragile” telomeres in 
MCF 10a cell line following siRNA of hnRNP A1 in 
comparison with mock treated or untreated samples (p<0.01). 
B) Increased frequency of “fragile” telomeres in MCF7 cells 
with siRNA depletion of hnRNP A1. Statistical analysis was 
done using student T-tests, and error bars represent standard 



































































siRNA silencing of hnRNP A1 leads to increased Telomere Sister Chromatid Exchange 
(T-SCE) frequency 
An increase in recombination has been reported at common fragile sites 
(Feichtinger and Schmid, 1989; Glover and Stein, 1987). Although telomeres are not 
historically defined as a “common” fragile site (Le Beau, 1986; Sutherland and Richards, 
1995), we further analyzed telomere integrity by performing two-color CO-FISH. Data 
were collected from three independent siRNA transfections and metaphase harvests. We 
observed an increase, approaching significance, in Telomere Sister Chromatid Exchange 
(T-SCE) frequency following siRNA knockdown of hnRNP A1 as compared to mock or 
untreated cells in the MCF7 cell line (Figure 4.7). This finding adds additional support to 
our conclusions in that the loss of hnRNP A1 influences telomere replication, evidenced 
by increased “fragile” telomeres and increased T-SCE. We note that increased T-SCE  
frequencies following hnRNP A1 siRNA depletion was not seen in MCF 10a cells. 
However, this was partly due to the very low frequency of T-SCE observed in general, 
where only five were seen in the untreated samples when scoring 90 metaphases. It is 
also likely that MCF7 and MCF 10a cells retain normal telomere regulation of Protection 
of Telomeres 1 (POT 1) and TRF 2 levels, which have been shown to repress T-SCE 
frequencies (Celli et al., 2006; Palm et al., 2009). Of the “fragile” telomeres that were 
observed, a slight, but not significant, bias toward telomeres produced via lagging strand 
synthesis (FITC-labelled C-rich probe, data not shown) was noted in the MCF7 cell line. 
Similar to the FISH data, we saw no increase in SFE. However, we observed a greater, 
not significant, increase in SFE using the Cy-3 probe in all three treatments in 











Figure 4.7. Increased T-SCE frequency in MCF7 cell line following siRNA 
depletion of hnRNP A1. A). Representative images of 2-color CO-FISH done in 
MCF7 cells. Panel on the right depicts T-SCE, where an exchange of both 
telomere sister chromatids was observed (yellow). B) T-SCE frequency in 
MCF7 cells and MCF 10a cells.  T-SCE increases following siRNA of hnRNP 
A1 in MCF7 cells. This increase was not quite significant (p=0.09) in MCF7 
cells. Little difference was observed in T-SCE frequency in the MCF 10a cell 
line. However, this may be due to the overall low background level of T-SCE. 
Statistical analysis was performed using Student T-tests. 
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were largely a reflection of probe and fluor efficiency in binding and not a true difference 
in strand specificity. Furthermore, the MCF 10a cell line did not exhibit a preference for a 
strand specific involvement in “fragile” telomeres. Taken together, we conclude that 
additional studies will be required to confirm/establish any strand-specificity or 
preference in the “fragile” telomere phenotype. Our results suggest that the “fragile” 
telomere phenotype was not strand specific.  
 
Discussion 
In this study, we show that the RNA binding protein hnRNP A1 is not essential 
for TERRA localization at mammalian telomere ends. We utilized a novel 3-D 
reconstruction strategy to evaluate co-localization of TERRA and TRF2 foci to examine 
this association. Similar to de Silanes et al. studies (de Silanes et al., 2010), we found no 
change in the localization pattern of TERRA at telomeres with reduced hnRNP A1 levels. 
However, using our 3-D imaging technique, we did observe a shift in TERRA/TRF2 
interaction at individual telomeres, as reflected in a lower Pearson‟s Correlation 
Coefficient, following siRNA depletion of hnRNP A1. This change may be due to 
changes in telomeric heterochromatin or a change in the interaction between TERRA and 
telomere ends (TRF2). In the de Silanes et al. study other members of the hnRNP family 
were also examined and shown to affect the localization of TERRA at telomeres, 
including hnRNP F, hnRNP M, hnRNP A2/B1and hnRNP D/AUF1 (de Silanes et al., 
2010). siRNA depletion of these hnRNPs increased the percent colocalization of TERRA 
with telomeres. They suggested this was due to the role of hnRNPs in repressing TERRA 




redundancy in function between the hnRNPs. For example although hnRNP A1 plays a 
critical role in mRNA splicing and shuttling, it is not essential for cell growth (Ben-David 
et al., 1992), suggesting other hnRNPs may also be involved in this function. Another 
possibility would be that hnRNP A1 is not completely silenced in our experiments. 
However, because our siRNA knockdown efficiency was high, ~90%, we find this 
unlikely.  
hnRNPs have been suggested to influence TERRA RNA stability, where loss of 
hnRNPs resulted in an increase in TERRA RNA levels (de Silanes et al., 2010). In order 
to examine if hnRNP A1 affected total TERRA expression levels, we performed RNA 
dot blots following siRNA silencing of hnRNP A1. We observed no changes in TERRA 
RNA levels following hnRNP A1 depletion (Figure 4.4). In contrast to the de Silanes 
studies, we did not examine changes in TERRA RNA levels at different time points 
following transcription inhibition. Therefore our results do not argue against a possible 
role for hnRNP A1 in enhancing TERRA RNA stability. Rather, this suggests that 
hnRNP A1 depletion does not affect TERRA RNA levels at 72 hours post treatment. In 
addition, in the de Silanes study, the observed increase in TERRA levels following the 
specific inhibition of hnRNP A1 was nominal and not significant. This suggests that of 
the hnRNPs, perhaps hnRNP A1 plays only a minimal role in TERRA stability.  
Because hnRNP A1 has been shown to influence telomere length and telomerase 
activity (Zhang et al., 2006), we also examined telomere function following siRNA 
silencing of hnRNP A1. We provide evidence that hnRNP A1 plays an important role in 
the efficient replication of telomeres in human mammary epithelial cells. We observed a 




previously termed “fragile” telomeres, in hnRNP A1 depleted cells (Sfeir et al., 2009). 
Sfeir et al. showed that this phenotype resembled that which is commonly seen when 
cells are treated with amphidicolin, a DNA polymerase-α inhibitor, thus further linking 
this phenotype to replication. An increase in sister chromatid recombination has 
previously been observed at fragile sites (Feichtinger and Schmid, 1989; Glover and 
Stein, 1987). An increase in exchange frequency has been proposed to result from 
unreplicated single stranded regions created by stalled fork progression (Painter, 1980). 
In this model, cells treated with agents that reduce fork progression maintain either single 
stranded regions or regions that replicate late in the cell cycle and have not fully 
condensed, making the area prone to exchanges. Consistent with this view, we observed 
an increase in T-SCE frequency that approached significance following siRNA treatment 
of hnRNP A1 in MCF7 cells. We observed little to no change in T-SCE frequencies in 
the MCF 10a cell line. However, this may be due to the overall low levels of T-SCE in 
the MCF 10a cell line. Because of this low number, a large number of metaphases may 
have to be analyzed before any difference in T-SCE frequency can be definitely 
determined. Furthermore, the low number of T-SCE frequency in MCF 10a, as well as 
the relatively low frequency in MCF7, may reflect other factors that regulate telomere 
recombination. For example, POT 1 and TRF2 have also been shown to repress T-SCE 
events (Celli et al., 2006; Palm et al., 2009).  
A role for hnRNP A1 in telomere replication has recently been suggested, as 
hnRNP A1 was observed to play a role in the removal of Replication Protein A (RPA) 
from telomere ends,  thereby allowing access for Protection Of Telomeres 1 (POT 1) 




been observed following siRNA of hnRNP A1, suggesting that removal of this hnRNP 
A1 initiates a damage response (de Silanes et al., 2010). RPA is vital in the activation of 
Ataxia-Telagectasia mutated and Rad 3 related (ATR) pathway, and it has been suggested 
that binding of POT 1 blocks access to RPA, preventing the activation of ATR signaling 
at telomere ends (Gong and de Lange, 2010). hnRNP A1 has also been shown to unwind 
G-quadruplex structures, common in G-rich sequences (Fukuda et al., 2002; Zhang et al., 
2006), such as telomeres. Therefore, hnRNP A1 may act to allow access to replication 
proteins during telomere replication.   
The question of how TERRA is associated with telomeres is poorly understood 
and an active area of investigation. Other members of hnRNP family have been 
implicated (de Silanes et al., 2010). Possible TERRA associations with Shelterin, the 
complex of proteins involved in protecting telomeres and t-loop formation (Griffith et al., 
1999), have also been suggested and may involve TRF1 and/or TRF2 (Deng et al., 2009). 
Here, we demonstrate that hnRNP A1 is not necessary in TERRA localization at 
telomeres, and hnRNP A1 does not influence overall TERRA levels. In addition, we 
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 Since Barbara McClintock and Herman Muller first identified telomeres, 
researchers have been seeking to define the mechanisms that maintain these unique 
structures and their critical functions (McClintock, 1941; Muller, 1938). With the 
identification of telomerase (Greider and Blackburn, 1985), the enzyme that extends 
telomere sequences, and its upregulation in cancer (Kim et al., 1994), the telomere 
biology field quickly expanded into and integrated with cancer research. The field 
continues to evolve as evidenced by the recent discovery of Telomere Repeat-containing 
RNA or Telomeric RNA (TERRA/TelRNA), which is transcribed from the telomere 
sequence (Azzalin et al., 2007; Schoeftner and Blasco, 2008). Telomere structure and 
function is maintained by a complex of proteins termed Shelterin, a host of associated 
proteins (de Lange, 2005). Critical loss of telomere length and/or the disruption of the 
telomere structure may result in chromosomal fusions and contribute to carcinogenesis.  
In these studies, we investigated the mechanisms of human telomere structure and 
function. 
The goal of the studies presented here was to 1) investigate the role of telomeres 
in radiation induced murine Acute Myeloid Leukemia (AML), 2) examine the effects of 
DNA Protein Kinase catalytic subunit (DNA-PKcs) kinase activity on TERRA 
localization to telomeres and 3) characterize the role of heterogeneous ribonuclear protein 
A1 (hnRNP A1) in TERRA localization at telomeres and telomere function. 
 
Increased genomic instability in radiation-induced murine AML  
 Chapter I described the dangers to astronauts during space travel, which includes 




to such a radiation exposure is largely uncertain. We provide evidence supportive of an 
association between genomic instability, seen as increased chromatid-type aberrations, 
and radiation-induced AML in CBA/Ca mice. Interestingly, increased frequencies of 
chromatid-type aberrations were specific to mice that developed AML and were seen in 
tumors following both ɣ- and 
56
Fe ion exposure. These results suggest that the increased 
frequencies of chromatid-type aberrations were not influenced by radiation quality, but 
rather are linked with AML development itself. Furthermore, we observed an initial 
increase in chromatid-type aberrations in spleen colonies, using the Colony Forming 
Unit-Spleen (CFU-S) assay, suggesting that such instability may occur early in tumor 
initiation. Chromatid-type aberration frequencies were not significantly different in ɣ- or 
(1 GeV/n) 
56
Fe-induced AML tumor samples. A slight relative biological effectiveness 
(RBE) was seen when examining AML induction following ɣ- or (1GeV/n) 
56
Fe 
irradiation in CBA/CaJ mice (Weil et al., 2009).  
 We observed little to no change in the frequency of telomere aberrations in 
murine AML tumor samples. Critically short telomeres have frequently been observed in 
carcinogenesis (Gisselsson et al., 2001). However, active telomerase in mice masks such 
telomere defects (Chadeneau et al., 1995; Prowse and Greider, 1995). Therefore, we also 
examined two human AML cell lines, KG-1a and UoC-M1. We observed a clonal 
aberration in the KG-1a cell line involving interstital telomeres. Evidence suggests that 
this telomere fusion event involves chromosomes 5 and 17 [(Mrozek et al., 2003) and 
personal correspondence with Michelle LeBeau]. This telomere fusion event provides 




chromosomal instability and emphasizes the importance of functional telomere structure 
and function.  
   
Implications and Future Directions 
Because chromosomal instability was specifically linked to tumor samples, it is 
possible that such instability provides a valuable measure of risk for radiation-induced 
AML. However, in order to more confidently assess cancer risk following radiation 
exposure, a stronger prognostic assessment could be achieved through the combination of 
chromatid-type aberration induction and genomic changes, such as the loss of PU.1 (Peng 
et al., 2009). 
 There is a vital need for a means to better assess AML risk following radiation 
exposure.  In order to better define this risk, an assessment of chromatid-type aberrations 
in human radiation-induced AML is essential. 
56
Fe exposure to humans is limited. 
Therefore, other types of radiation must be examined. For example, chromatid-type 
aberrations should be assessed in patients treated following radiotherapy. Patients that 
develop AML as a secondary cancer would need to be examined. Unfortunately, the 








The interactions of DNA dependent protein kinase catalytic subunit (DNA-PKcs), 
telomere repeat-containing RNA (TERRA), and heterogenous nuclear 
ribonucleoprotein A1 (hnRNP A1) in telomere function and structure  
DNA-PKcs dependent phosphorylation of hnRNP A1  
We confirmed decreased phosphorylation of hnRNP A1 following siRNA 
silencing of DNA-PKcs in two human mammary epithelial cell lines,  MCF7 
(tumorigenic) and MCF 10a (non-tumorigenic), by examining metabolic Phosphorus-32 
(
32
P) uptake followed by immunoprecipitation of hnRNP A1. We observed decreased 
phosphorylation of hnRNP A1 in MCF7 cells following inhibition of DNA-PKcs kinase 
activity with 2-(Morpholin-4-yl)-benzo[h]chromen-4-one (NU7026) but did not see a 
significant change in hnRNP A1 phosphorylation in MCF 10a cells. This finding is 
consistent with the previous observation that DNA-PKcs phosphorylation of hnRNP A1 
is influenced by the presence of the human telomerase RNA component (hTR) (Ting et 
al., 2009), and MCF 10a cells have been shown to have decreased hTR expression and 





following siRNA silencing of DNA-PKcs may be due to an indirect 
affect on related kinases, such as ATM (Peng et al., 2005).   It is likely that other kinases 
target hnRNP A1, as 
32
P-labelled signal remains following the siRNA depletion of DNA-
PKcs. Many kinases have been implicated in phosphorylating hnRNP A1, including 
protein kinase A (Cobianchi et al., 1993), p38 MAP kinase (Shimada et al., 2009), protein 






DNA-PKcs kinase activity and TERRA localization at telomeres  
 DNA-PKcs has previously been shown to phosphorylate hnRNP A1 (Ting et al., 
2009; Zhang et al., 2004) and play a role in telomere end capping function (Bailey et al., 
2004; Bailey et al., 1999). We, therefore, also examined the affects of DNA-PKcs kinase 
activity on the localization of TERRA to telomeres, hypothesizing a mechanism of action 
through hnRNP A1.  
siRNA depletion of DNA-PKcs has been previously shown to also decrease levels 
of ATM (Peng et al., 2005).  We, therefore, treated cells with NU7026, a specific DNA-
PKcs kinase activity inhibitor at low concentrations (Hollick et al., 2003) and examined 
TERRA localization at telomeres. We combined RNA Fluorescence In Situ Hybridization 
(FISH) and immunocytochemistry (ICC) with a probe specific to TERRA and an 
antibody against telomere repeat factor 2 (TRF2). We did not observe a significant 
change in TERRA localization to telomeres following NU7026 treatment in the MCF7 
cell line. These results suggest that DNA-PKcs kinase activity is not required for TERRA 
localization at telomeres. Interestingly, we did observe a slight decrease in TRF2 and 
TERRA foci overlap at individual telomeres following DNA-PKcs kinase inhibition. This 
was observed both visually and by a lower Pearson‟s Correlation Coefficient when using 
3-D imaging. This suggests that DNA-PKcs may indirectly facilitate telomeric 
heterochromatin or TERRA/TRF2 interaction. These findings are preliminary and more 







TERRA levels decrease following DNA-PKcs kinase inhibition 
 We examined overall effects on TERRA levels following DNA-PKcs kinase 
activity inhibition using RNA dot blots. TERRA levels in the MCF 10a cell line were 
sensitive to Dimethyl Sulfoxide (DMSO) treatment, as TERRA levels were decreased in 
both the DMSO control and NU7026 treated. However, we observed little to no change in 
TERRA levels following kinase inhibition in the MCF 10a cell line. Various members of 
the hnRNPs have been implicated in TERRA stability, where loss of hnRNP F led to 
increased levels of TERRA (de Silanes et al., 2010). This was believed to be due to the 
role of hnRNP F in pre-mRNA cleavage. Similarly, hnRNP A1 also plays a role in pre-
mRNA processing (He and Smith, 2009). Because transcription has been shown to be 
affected by DNA-PKcs (Chibazakura et al., 1997; Dvir et al., 1992; Peterson et al., 1992; 
Peterson et al., 1995; Sheppard and Liu, 2000) and hnRNP A1 mRNA binding affected 
by phosphorylation (Buxade et al., 2005), decreases in TERRA levels following DNA-
PKcs kinase inhibition in the MCF7 cell line may be due to a combination of decreased 
transcription and decreased hnRNP A1 interaction with TERRA (Figure 5.1). 
 
 The role of hnRNP A1 in telomere structure and function 
hnRNP A1 is not necessary for TERRA localization at telomeres 
Because hnRNP A1 preferentially binds UUAGGG/U sequences (Burd and 
Dreyfuss, 1994) and has been shown to play a role in telomere biology (Zhang et al., 
2006), we hypothesized that hnRNP A1 plays a role in “tethering” TERRA at telomere 







Figure 5.1. Diagram depicting DNA-PKcs, hnRNP A1 and TERRA interactions. The hTR dependent 
phosphorylation of hnRNP A1 by DNA-PKcs leads to decreased hnRNP A1 interaction. hnRNP A1 has 
been shown to enhance telomerase activity, and we propose it is important in efficient telomere replication. 
Furthermore, DNA-PKcs kinase activity may be important in regulating TERRA levels through its roles in 
transcription. Future directions include examining how DNA-PKcs dependent (de)-phosphorylation of 





hnRNP A1 with TERRA (de Silanes et al., 2010). We investigated the role of hnRNP A1 
in TERRA localization at telomeres by combining RNA FISH with ICC using a probe 
specific to TERRA and an antibody toward TRF2. In order to evaluate the role of hnRNP 
A1 in TERRA localization, we targeted hnRNP A1 using small interfering (si) RNA 
transfection with an oligonucleotide specific to hnRNP A1. We saw little to no change in 
TERRA localization at telomeres, suggesting that hnRNP A1 is not necessary in TERRA 
localization at telomere ends.  However, we cannot exclude redundancy in function 
among the hnRNP family of proteins, as supported by data showing that cells may still 
proliferate with silencing of hnRNP A1 although it plays a vital role in mRNA splicing 
(Ben-David et al., 1992). This is suggested in the Silanes et al. study, where siRNA 
depletion of other hnRNP members led to a significant  increase in TERRA localization 
to telomeres, including hnRNP F, hnRNP M, hnRNP A2/B1 and hnRNP A1 and D/AUF1 
(de Silanes et al., 2010).  
 Interestingly, we did observe minor decreases in TRF2 and TERRA overlap using 
our 3-D imaging technique following siRNA targeting of hnRNP A1 in colocalized foci. 
This was reflected in a decreased average of Pearson‟s Correlation Coefficient for a small 
subset of the cells and suggests a possible shift in telomeric heterochromatin structure 
and/or TERRA and telomere (TRF2) interactions. In addition, we observed a similar, less 
dramatic, change in TERRA and TRF2 foci overlap following DNA-PKcs kinase 
inhibition. This suggests that this decrease in TRF2 and TERRA foci overlap may be due 
to changes targeting hnRNP A1, where its depletion leads to a more notable change. 
These preliminary results imply that hnRNP A1 may function to facilitate telomeric 




research is required, as we cannot discount changes in cell cycle, where heterochromatin 
structure naturally shifts. Telomeres of replicating cells in S-phase would be expected to 
lose telomere associated proteins due to unraveling of the telomere structure to allow 
access of replication machinery. Because TERRA is found to be decreased during S-
phase (Flynn et al., 2011; Porro et al.), we are naturally selecting cells outside of S-phase. 
However, we cannot disregard the concern that we are not excluding cells in early S-
phase, where shifts in heterochromatin and protein interactions may occur.  
 
hnRNP A1 does not influence TERRA levels 
 A previous study found that TERRA levels increased with siRNA knockdown of 
various hnRNPs, particularly hnRNP F (de Silanes et al., 2010). We, therefore, examined 
TERRA levels following hnRNP A1 depletion but found no significant change in 
TERRA levels with decreased hnRNP A1. Similarly in the de Silanes et al. study, hnRNP 
A1 knock down showed only nominal effects on TERRA levels, where as hnRNP F 
exerted a stronger influence on TERRA levels (de Silanes et al., 2010).  
 
Silencing of hnRNP A1 leads to “fragile” telomeres 
 Telomere replication is inherently difficult due to the highly repetitive sequence 
and propensity to form secondary structures, including G-quadruplex structures (Gilson 
and Geli, 2007).  Recently, it was shown that TRF1 is required for efficient telomere 
replication, where conditional knockout of TRF1 led to a “fragile” telomere phenotype 




aphidicolin, a DNA polymerase α inhibitor, which is frequently used to identify common 
fragile sites.  
 In Chapter 4, we observed a similar “fragile” telomere phenotype following 
siRNA silencing of hnRNP A1 in two human mammary epithelial cell lines, defined as 
telomere duplicates or extended telomere signal on a single chromatid. hnRNP A1 has 
recently been proposed to be important in the displacement of Replication Protein A 
(RPA) at telomere ends (Flynn et al., 2011), providing one possible role for hnRNP A1 in 
replication. Another possible role for hnRNP A1 in replication may involve its role in 
unwinding G-quadruplex structures (Zhang et al., 2006).  Here we propose that hnRNP 
A1 is important in efficient telomere replication. Furthermore, it is interesting to postulate 
that this interaction may be intimately linked to its ability to stimulate telomerase activity 
(Zhang et al., 2006), functioning to allow access to telomerase and/or recruit telomerase 
to telomere ends. 
 We observed a bias towards the “fragile” telomere phenotype in telomeres 
produced via lagging strand synthesis in MCF7 cells. We also noted an increase in signal 
free ends (SFE) involving the telomere produced via leading strand synthesis. 
Furthermore, the FITC-labeled C-rich probe that labels the telomeres produced via 
lagging strand synthesis has an inherently higher background than the Cy-3 fluor used in 
labeling the strand produced via leading strand synthesis. In addition, we did not observe 
a strand bias for the “fragile” telomere phenotype in the MCF 10a cell line. Taken 
together, our data suggests that the “fragile” telomere phenotype was not strand specific, 
and a similar conclusion was reached following conditional knockout of TRF1 (Sfeir et 




label the G-rich probe with FITC and the C-rich probe with Cy-3, and re-examination of 
“fragile” telomeres would be necessary.  
 
Future Directions 
 DNA-PKcs is an multifunctional protein involved in Non-Homologous End 
Joining (NHEJ) (Allalunis-Turner et al., 1995; Okayasu et al., 1998), DNA replication 
(Allen et al., 2011), telomere end-capping function (Bailey et al., 2001; Bailey et al., 
1999) and transcription (Chibazakura et al., 1997; Peng et al., 2005; Peterson et al., 
1995). We examined possible mechanisms underlying DNA-PKcs mediated telomere 
function. Although we did not observe decreased TERRA localization to telomere 
following either DNA-PKcs kinase activity inhibition or siRNA depletion of hnRNP A1, 
we did observe a decrease in the degree of overlap between TERRA and individual 
telomeres in MCF7 cells. We are actively collecting data in the MCF 10a cells. Our 
future directions include exploring this interaction. We found that DNA-PKcs does 
influence TERRA levels, therefore a future direction would be to determine how. One 
possible target is RNA polymerase II, a known phosphorylation target for DNA-PKcs 
(Dvir et al., 1992) which has been shown to partially transcribe TERRA (Azzalin et al., 
2007; Schoeftner and Blasco, 2008). In order to examine this possibility, phosphorylation 
mutants of RNA polymerase II could be used to examine TERRA levels. 
 hnRNP A1 has been shown to bind TERRA in vivo and affect TERRA stability 
(de Silanes et al., 2010). We showed that hnRNP A1 was not necessary for the 
localization of TERRA at telomere ends. However, the question of whether or not hnRNP 




examine this, one possible experiment would be to inhibit transcription via treatment with 
α-amanitin, an RNA polymerase II inhibitor combined with siRNA silencing of hnRNP 
A1, then examine TERRA expression over time. If hnRNP A1 indeed affects stability, 
one would imagine increased TERRA degradation over time in comparison to sample 
with normal hnRNP A1 expression. Furthermore, the question of whether 
phosphorylation of hnRNP A1 affects its binding to TERRA also remains unanswered. 
Use of phosphorylation mutants of hnRNP A1, such as those developed by Ting et al. 
(Ting et al., 2009) and performing gel shift assays in order to examine TERRA binding 
changes in vitro would be informative in this regard. 
 
MicroRNA (miRNA) expression following hnRNP A1 depletion 
 The regulation of miRNA has recently been shown to influence telomeric 
heterochromatin structure (Benetti et al., 2008). In this study, a deficiency in dicer, a 
protein vital in mature miRNA processing (Grishok et al., 2001; Hutvagner et al., 2001; 
Ketting et al., 2001), led to increased levels of mir-290 that targeted and consequently 
silenced Retinoblastoma-like 2 protein (Rbl2) (Benetti et al., 2008). Decreased Rbl2, in 
turn, resulted in decreased DNA methyltransferases, decreased DNA methylation and 
increased telomeric recombination, suggesting telomere heterochromatin structure may 
be influenced by miRNA.  LET-7 is a miRNA correlated with the development and 
terminal differentiation in caenorhabditis elegans (Reinhart et al., 2000) and a proposed 
tumor suppressor (Johnson et al., 2007; Yu et al., 2007). Because hnRNP A1 has also 
been shown to negatively regulate levels of LET- 7 by inhibiting pre-mature LET-7 




microarray analysis following siRNA depletion of hnRNP A1 in order to identify 
possible miRNA that may influence telomere function and/or structure (listed in 
Appendix II). We observed no significant changes in miRNA expression following 
siRNA depletion of hnRNP A1 in the MCF7 cell line. However, many miRNA of interest 
were downregulated following siRNA depletion of hnRNP A1 in the MCF 10a cell line.  
In contrast to evidence that overexpression of hnRNP A1 leads to decreased LET-7a, we 
observed nearly a five-fold decrease in miRNA in the LET-7 family following siRNA 
depletion of hnRNP A1 (Michlewski and Caceres, 2010). We also observed a substantial 
decrease in miRNA-106b (~four-fold) following siRNA depletion of hnRNP A1. 
miRNA-106b has also been shown to target Rbl2, suggesting a possible link between 
hnRNP A1 and telomere heterochromatin structure. Validation of identified miRNA 
candidates by quantitative real-time Polymerase Chain Reaction (PCR) is still required, 
and this is an active area of our future research. miRNA expression array data are listed 
in Appendix II. 
Telomere maintenance and regulation continues to be complex and ever evolving. 
With the recent discovery of telomere repeat-containing RNA (TERRA), another level of 
regulation has been added to the maintenance of telomere structure. We explored the 
mechanisms of telomere structure and function, and we provide new insight into possible 
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MicroRNA array methods 
 
 Total RNA was collected using a Qiagen RNeasy Plus Mini Kit (Qiagen 74134), 
which includes the collection of small RNAs. DNA-free RNA quality was tested by gel 
electrophoresis. miRCURY LNA microRNA Array Spike-in kit v2 (Exiqon) was used as 
a control for the labeling reaction and hybridization. A total of 1.5 ug of RNA was 
labeled with Hy 3 fluor using the Hi-Power labeling kit (Exiqon), as suggested by the 
manufacturer. Briefly, 1.5 ug RNA in 3uL volume, 1uL spike-in miRNA kit v2, 0.5uL 
Calf Intestinal Phosphatase (CIP) buffer and 0.5 uL CIP enzyme was mixed on ice and 
incubated at 37ºC for 30 minutes. The RNA was then denatured at 95ºC and immediately 
placed on ice for 2 minutes. This reaction product is then mixed with 3 uL Hi-Power 
labeling buffer, 1.5 uL Hy3 fluorescent label, 2 uL Dimethyl Sulfoxide (DMSO) and 1 
uL Hi-Power labeling enzyme for a total of 12.5 uL total volume. This is incubated for 2 
hours at 16ºC. Samples are subsequently hybridized to microarray slides (Exiqon 
miRCURY LNA microRNA array kit) using the Nimble Gen/MAUI 4-Bay hybridization 
station, as suggested by the manufacturer. The labeled RNA is brought up to a 25 uL 
volume and 25 uL of hybridization buffer is added, for a total of 50 uL volume. 
Following denaturation at 95ºC for 2 minutes, the sample was iced for 2 minutes. The 
sample is then heated to 56ºC, and the total sample is added to the microarray slide, and 
hybridization occurs for 16 hours at 56ºC in the hybridization chamber. Slides are then 
washed for 1 minute at 56ºC in wash buffer A, 1 min at 23ºC in wash buffer B and 1 




Slides are then dried for 5 minutes. Microaray slides are scanned using the Tecan‟s 
Power Scanner. Spot quantification, image and statistical analysis were done using 
Imagene 9 and Nexus Expression 2 software, both from Exiqon. Background substraction 
was done by subtracting the median local background, and normalization was done using 







MicroRNA Array Data 
Data was collected and analyzed from prepared RNA samples by Dr. Michael Story 
*Minor miRNA 
**Not all validated target genes provided to us were listed 
 
I. MCF 7 mock transfected versus MCF 7 siRNA depletion of hnRNP A1 
a. N/A: no significant results 
 
II. MCF 10a mock versus siRNA depletion of hnRNP A1 
a. A positive Fold change represents an increase in mock, i.e. decrease in 
siRNA treated cells 



















CSF1, TAC1 5.463 0.031 
hsa-miR-130b 
 


































































  4.820 0.013 
hsa-miR-374c 
 
  4.783 0.014 
hsa-miR-20a* 
 
  4.751 0.020 
hsa-miR-3660 
 
  4.680 0.048 
hsa-miR-708 
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hsa-miR-342-3p 
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hsa-miR-601 
 
  3.021 0.036 
hsa-let-7i* 
 



















  3.003 0.026 
hsa-miR-4329 
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ACVR1, TSPAN3 2.924 0.042 
hsa-miR-3175 
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NTRK3 2.795 0.042 
hsa-miR-1273e 
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hsa-miR-106b* 
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III. MCF7 mock transfected versus MCF 10a mock transfected 
a. N/A: no significant results 
 
IV. MCF7 siRNA depletion of hnRNP A1 versus MCF 10a siRNA depletion of hnRNP 
A1 
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List of Abbreviations 










A-bomb Atomic bomb 
ABCC Atomic Bomb Casualty Commission 
ALT Alternative Lengthening of Telomeres 
AML Acute Myeloid Leukemia 
ARG Arginine 
ATM Ataxia Telangiectasia Mutated 
ATP Adenosine Triphosphate 
ATR Ataxia Telangiectasia and Rad3 Related 
BAC Bacterial Artificial Chromosome 
BER Base Excision Repair  
BFB Breakage-Fusion-Bridge 
Bp Base pairs 




BRCA2 Breast Cancer 2 
BrdC Bromodeoxycytidine 
BrdU Bromodeoxyuridine 
BSA Bovine Serum Albumin 
CCD Charged-Coupled Device camera 
cDNA complementary DNA 
Ci Curie 
CIN Chromosomal Instability 
CIP Calf Intestinal Phosphatase 
CFU-A Colony Forming Unit Assay 
CFU-S Spleen Colony Forming Unit  
CO2 Carbon Dioxide 




CTD Carboxyl Terminal Domain 
D-loop Displacement loop 
DAPI 4',6-diamidino-2-phenylindole, dihydrochloride 
ddH20 Deionized distilled water 
DKC Dyskeratosis Congenita 
DMEM Dulbecco‟s Modified Eagle‟s Medium 
DMSO Dimethyl Sulfoxide 
DNA Deoxyribonucleic Acid  




DNA-PKcs DNA Dependent Protein Kinase catalytic subunit 
DSB Double-Strand Break 
dsDNA double-stranded DNA 
E Energy 
EBSS Earle‟s Balanced Salt Solution 
EDTA Ethylenediaminetetraacetic Acid 
EGF Epidermal Growth Factor 
EGTA Ethylene Glycol Tetraacetic Acid 
ES Embryonic Stem 
ETS E-Twenty-Six 
FBS Fetal Bovine Serum 
Fe Iron 
FISH Fluorescence In Situ Hybridization 
g gram 
GCR Galatic Cosmic Rays 
GeV Giga electron Volt 
GeV/n Giga electron Volt/nucleon 
GM-CSF Granulocyte-Macrophage Colony-Stimulating Factor 
GSR Galatic Space Radiation 
Gy Gray 
H3K4me3 Histone H3 trimethyl 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic Acid 
hnRNP A1 Heterogeneous nuclear Ribonucleoprotein A1 
HP1 Heterochromatin Protein 1 




hTR Human telomerase RNA component 
HZE Highly ionizing, High Energy radiation 
ICC Immunocytochemistry 
IMDM Iscove's Modified Dulbecco's Media 
IP Immunoprecipitation 
IR Ionizing Radiation 
ITS Interstitial Telomere Sequence 
Kbp Kilo base pairs 
KCL Potassium Chloride 
LET Linear Energy Transfer 
LSM Lymphocyte Separation Media 
LSS Life Span Study 
M-CSF Macrophage-Colony Stimulating Factor 
MACs Magnetic Sorting Buffer 
MDS Myelodysplastic Syndrome 
MEM Minimum Essential Media 
miRNA microRNA 
mL milli Liter 
mM milli Molar 
MMR Mismatch Repair 
MNCs Mononuclear Cells 
MNK Map kinase signaling-integrated kinases 
MRN Mre11, Rad50 and Nbs1 
mRNA messenger Ribonucleic Acid 




NHEJ Non-Homologous End Joining 
nM nano Molar 
NMD Nonsense-Mediated Decay 
NSRL    NASA Space Radiation Laboratory  
NT    Non-target 
NU7026   2-(Morpholin-4-yl)-benzo[h]chromen-4-one 
O2    Oxygen 
ORC    Origin of Recognition Complex 
32
P    Phosphorus-32 
PAGE    Polyacrylamide Gel Electrophoresis 
PBS    Phosphate Buffered Saline 
PCR    Polymerase Chain Reaction 
PI-3-K Phospatidylinositol 3-kinase 
PIKK Phosphoinositide 3-kinase like 
PMSF Phenylmethylsulfonyl Fluoride 
PNA Peptide Nucleic Acid 
POT 1 Protection Of Telomeres 1 
PVDF Polyvinylidene Fluoride 
RBE Relative Biologic Effectiveness 
Rbl2 Retinoblastoma-like 2 protein 
RNA Ribonucleic Acid 
ROS Radical Oxygen Species 
RPA Replication Protein A 
RPMI Roswell Park Memorial Institute 




SDS Sodium Dodecyl Sulfate  
SDS-PAGE Sodium Dodecyl Sulfate –Polyacrylamide Gel 
Electrophoresis 
SER Serine 
SFE Signal Free Ends 
siRNA small interfering Ribonucleic Acid 
SMG Suppressors with Morphogenetic defects in Genetalia 
SPE Solar Proton Events 
SSC Saline Sodium Citrate 
Sv Sieverts 
t-AML Therapy-related Acute Myeloid Leukemia 
T-loop Telomere loop  
T-SCE Telomere Sister Chromatid Exchange 
TBST Tris-Buffered Saline with 0.1% Tween 20 
TelRNA Telomeric RNA 
TERC Telomerase RNA Component 
TERRA Telomeric repeat-containing RNA 
TERT Telomerase Reverse Transcriptase 
TFRC Transferrin Receptor 
THR Threonine 
TIF Telomere Induced Foci 
TNFα Tumor Necrosis Factor Alpha 
TRF1 Telomere Repeat Factor 1 
TRF2 Telomere Repeat Factor 2 
Trp53 Transformation related protein 53 
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UV Ultraviolet 
V Volt 
WRN Werner 
Z Charge 
 
 
